JPH0369332B2 - - Google Patents
Info
- Publication number
- JPH0369332B2 JPH0369332B2 JP61122049A JP12204986A JPH0369332B2 JP H0369332 B2 JPH0369332 B2 JP H0369332B2 JP 61122049 A JP61122049 A JP 61122049A JP 12204986 A JP12204986 A JP 12204986A JP H0369332 B2 JPH0369332 B2 JP H0369332B2
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- aqueous solution
- solution
- concentration
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 77
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 76
- 229960000187 tissue plasminogen activator Drugs 0.000 claims description 76
- 239000000243 solution Substances 0.000 claims description 48
- 239000007864 aqueous solution Substances 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 25
- 238000009472 formulation Methods 0.000 claims description 23
- 208000007536 Thrombosis Diseases 0.000 claims description 16
- 150000001413 amino acids Chemical group 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 239000012752 auxiliary agent Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 108020004511 Recombinant DNA Proteins 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 description 19
- 239000008194 pharmaceutical composition Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 102000001938 Plasminogen Activators Human genes 0.000 description 8
- 108010001014 Plasminogen Activators Proteins 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 238000001802 infusion Methods 0.000 description 8
- 229940127126 plasminogen activator Drugs 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
- 229920000053 polysorbate 80 Polymers 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- 239000012736 aqueous medium Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000012931 lyophilized formulation Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002537 thrombolytic effect Effects 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 101150074155 DHFR gene Proteins 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000010378 Pulmonary Embolism Diseases 0.000 description 2
- 108010023197 Streptokinase Proteins 0.000 description 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000020764 fibrinolysis Effects 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 102000047823 human PLAT Human genes 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 239000003182 parenteral nutrition solution Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960005202 streptokinase Drugs 0.000 description 2
- 229960005356 urokinase Drugs 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 108010014172 Factor V Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010023237 Jugular vein thrombosis Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex⢠Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229940089206 anhydrous dextrose Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- BRHPBVXVOVMTIQ-ZLELNMGESA-N l-leucine l-leucine Chemical compound CC(C)C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O BRHPBVXVOVMTIQ-ZLELNMGESA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical group 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000033885 plasminogen activation Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯çµç¹ãã©ã¹ãããŒã²ã³æŽ»æ§åå åãç¹
ã«çµç¹ãã©ã¹ãããŒã²ã³æŽ»æ§åå åãå«æããå»
è¬çµæç©ããããã®è£œé ããã³ãããã®ãããã
ã³åç©å»çã«ããã䜿çšã«é¢ããã è¡å¡ã圢æã§ããé µçŽ ç³»âåè¡ç³»âãšè¡å¡ã溶
解ã§ããé µçŽ ç³»âãã€ããªã³æº¶è§£ç³»ãšã®éã®å¥å š
ãªéæŸç¶è¡ç®¡åºãç¶æããŠããåçåè¡¡ãããã
ã®ãšèããããŠãããæå·ããã®å€±è¡ãå¶éãã
ããã«ãæå·ããè¡ç®¡ã«ã¯è¡å¡ã圢æããããæ
å·ãèªç¶ã«å埩ãããåŸã«ãäœåã®è¡å¡ã¯ãã€ã
ãªã³æº¶è§£ç³»ã®äœåã«ãã溶解ããããæã«ã¯ãè¡
å¡ãå€å·ããšããªãããšãªã圢æãããããã¯äž»
èŠè¡ç®¡ã«ãšã©ãŸãããšããããè¡æµãéšåçã«ãŸ
ãã¯å šäœçã«ãããéå¡ããçµæããããããã
ããå¿èãèºãŸãã¯è³ã§çãããšãå¿çæ¢å¡ãèº
å¯æ çãŸãã¯åäžãçºçãããããšãããããã
ãã®çµåãçç¶ã¯å·¥æ¥åœã«ããã眹ç çããã³æ»
亡çã®äž»èŠå ã§ããã è¡å¡ã¯ã¿ã³ãã¯åè§£é µçŽ ãã©ã¹ãã³ã«ãã溶解
ããããç¹ç¶ç¶²ç¶æ§é ãããªãããã®é µçŽ ã¯äžæŽ»
æ§ãªããé µçŽ ãã©ã¹ãããŒã²ã³ïŒããã¯è¡æŒ¿ã®æ
åã§ããïŒãããã©ã¹ãããŒã²ã³æŽ»æ§åå åã®äœ
çšã«ããèªå°ããããïŒçš®ã®å ç«åŠçã«ç°ãªãåº
ä¹³åç©ãã©ã¹ãããŒã²ã³æŽ»æ§åå åãååšããã
ãŠããããŒãŒãšããŠãç¥ãããŠããå åšæ§ãã©ã¹
ãããŒã²ã³æŽ»æ§åå åã¯è èã«ããç£çãããé µ
çŽ ã§ãããå°¿ããåé¢ã§ãããããã¯ãŸãå€ãã®
çµç¹å¹é€æºãããçæã§ãããè¡ç®¡ãã©ã¹ãããŒ
ã²ã³æŽ»æ§åå åãšããŠããã³çµç¹ãã©ã¹ãããŒã²
ã³æŽ»æ§åå åïŒïœâPAïŒãšããŠãç¥ãããŠãã
å€åšæ§ãã©ã¹ãããŒã²ã³æŽ»æ§åå åã¯ããªãã®çµ
ç¹ãã¢ãžããŒãïŒç¹ã«ããåå®®ïŒãè¡ç®¡çŽ°èå£ã
ãã³ããã€ãã®çŽ°èå¹é€ç©ããåé¢ã§ããããã
ãã®ïŒçš®ã®ãã©ã¹ãããŒã²ã³æŽ»æ§åå åã«å ã
ãŠãããŒã¿ãŒâè¡æ¶²æº¶è§£æ§ã¹ãã¬ããã³ãã·
ïŒstreptococciïŒããçæããã现èçæç©ãã¹
ãã¬ãããããŒãŒãããããŠããããŒãŒããã³ã¹
ãã¬ãããããŒãŒã®äž¡æ¹ãä»éããäž»èŠãªæ¬ ç¹ã¯
ãããã埪ç°åšç³»å šäœã«æŽ»æ§ã§ãããè¡å¡ã®éšäœ
ã§ã ã掻æ§ã§ã¯ãªãããšã«ããããããã¯ãããš
ãã°ãã€ããªããŒã²ã³ãããããã³ãã³ããã¢ã¯
ã¿ãŒïŒ¶ããã³ãã¢ã¯ã¿ãŒã®ãããªãã®ä»ã®è¡æ¶²
ã¿ã³ãã¯ãç Žå£ããããããŠè¡å¡åœ¢æèœåãæžã
ããã³åºè¡ã®å±éºãå¢å€§ããããããã«å¯ŸããŠã
ïœâPAã®çç©åŠç掻æ§ã¯ïœâPAãçµåããŠã
ããããã掻æ§åããããã€ããªã³ã®ååšã«äŸå
ãããããããŠãæ倧掻æ§ãè¡å¡ã®å Žæãããªã
ã¡æº¶è§£ããããšãããã€ããªã³ç¶²ç¶æ§é ã®ååšã
ãå Žæã§ã ãçããããã¯åºè¡ã®å±éºãæ Œå¥ã«å
é¿ãããã ïœâPAæäžã®äž»èŠçµè·¯ã¯è¡ç®¡å æ³šå ¥ã§ããã
åŸã€ãŠéçµè žæäžçšæº¶æ¶²ãšããŠãïœâPAã®è£œå€
ãèŠæ±ããããã¿ã³ãã¯è³ªã®å Žåãå»åž«ãŸãã¯ç£
å»åž«ã«è¬åãåçµä¹Ÿç¥å»è¬çµæç©ãšããŠæäŸãã
ããšã奜ãŸãããããã¯æ¶²äœè£œå€ã«ãŸãããã®æ
æã®ç§»éããã³è²¯èµé·æã«ãããã®ã§ããããã
ããªããããã¥ãã®ãã®ãããªåçµä¹Ÿç¥è£œå€ãäž
åœã«äžäŸ¿ã§å°é£ãªåé¡ãä»éããããšãªãææã®
éçµè žæäžçšæº¶æ¶²ã«å®¹æã«å€æã§ããããã³å»åž«
ãŸãã¯ç£å»åž«ããã®è£œå€ã滎éã®æº¶å€äžã§åæ§æ
ããããšã«ããåçŽã«ãã¥ããæå®ã®ç¶æ³ã«èŠæ±
ãããæ¿åºŠãåŸãããšãã§ããããšãéèŠã§ã
ããããšãã°ãå¿èãŸãã¯è èã®é害ãæããæ£
è ã«å€§éã®æº¶æ¶²ãæäžããããšã¯ãæ£è ã®å¿èãŸ
ãã¯è èã«ãã倧ããããšããããã¹ãã¬ã¹ãäž
ããããšããæãŸãããªããåŸã€ãŠãæäžå®¹éã¯
ãã®ãããªç¶æ³ã§æäœã«ç¶æãããã¹ãã§ããã
åŸã€ãŠãéçµè žæäžçšæº¶æ¶²ã¯æ¯èŒçäœæ¿åºŠã§ãã
ã°ããã§ãªãããŸãé«ãè¬ç©æ¿åºŠãæãããã®ãš
ããŠåŸãããšãã§ããããšãæãŸããã ïœâPAã®å€ãã®åçµä¹Ÿç¥å»è¬è£œå€ãåŸæ¥æè¡
ã§ãããšãã°EPââ113319ããã³EPââ
123304ã«é瀺ãããŠããããããã®è£œå€ã¯ãã®PH
ãã»ãŒäžæ§ã§ããïœâPAã®æ°Žæ§å¡©é¡æº¶æ¶²ãã補
é ããããã®ãããªæº¶æ¶²äžã«ãããïœâPAã®æº¶
解床ã¯ã€ãªã³æ§æ¿åºŠãå¢å ããªããšäœããšããæ¬
ç¹ãæãããåŸã€ãŠããã®ãããªåçµä¹Ÿç¥è£œå€ã
ãåŸãããéçµè žæäžçšæº¶æ¶²ã¯æãç¶æ³ã§ã¯æãŸ
ãããªã倧éã®æº¶æ¶²ãæ£è ã«æäžããå¿ èŠããã
ã»ã©äœãæ¿åºŠã§ïœâPAãå«æããŠãããããŸã
ã¯é«åŒµæ§ã§ãã€ãŠãæäžãããšèµ€è¡çã«å¯ŸããŠæ
害ã§ããããšããããã®ãã¥ããã§ããã ããã«ãïœâPAã®æ°Žæº¶æ¶²äžã«ããã溶解床ãã
溶液ã®PHãé žçŽ ç¯å²å ã«ãããšæ¹åã§ããããšã
åçµä¹Ÿç¥å»è¬è£œå€ãïœâPAã®é žæ§æº¶æ¶²ãã補é
ã§ããããšãããã³ãã®è£œå€ãæäžããå Žåã«æ
æã®ççåŠçåé¡ã瀺ããªãéçµè žæäžçšæº¶æ¶²ã
æäŸã§ããããšãèŠãåºããããåŸã€ãŠãæ¬çºæ
ã¯ïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ã補é ããæ¹æ³ã
æäŸãããã®æ¹æ³ã¯PHãïŒãïŒã§ããïœâPAã®
å·å氎溶液ã也ç¥ãããããšãããªãæ¹æ³ã§ã
ãã ïœâPAã®æ¹åããã溶解床ã®çµæãšããŠãïœ
âPAã溶液ããæ²æŸ±ããæåºãããã¥ããã®å®
質çãªå±éºãä»éããããšãªããé«æ¿åºŠã§ïœâ
PAãå«æããéçµè žæäžçšæº¶æ¶²ãæäŸã§ããå
çµä¹Ÿç¥å»è¬è£œå€ãæ¬çºæã«åŸã補é ã§ãããåŸã€
ãŠãæ¬çºæã«ããå¿ èŠãªæããã³å¿ èŠãªå Žåã«ã
補å€ãããšãã°äžæ§ãŸãã¯é žæ§PHã®æ°Žã䜿çšããŠ
ææã®æ¿åºŠã«æº¶è§£ã§ããå»åž«ãŸãã¯ç£å»åž«ã«åçµ
也ç¥è£œå€ãæäŸã§ãããããªãã¡ãæ¬çºæã¯ãã®
åãæ±ãã極ããŠæè»ã§ãã€ãŠãå»åž«ããã³ç£å»
åž«ã«ãã䜿çšã§ããå®å®ãªåçµä¹Ÿç¥å»è¬è£œå€ãæ
äŸãããšãšãã«ã移éããã³è²¯èµãããã«ç°¡äŸ¿ãª
æ段ãæäŸããã æ¬çºæã§äœ¿çšããïœâPAã¯åºä¹³åç©ã«å®è³ªç
ã«å¯Ÿå¿ãããã¥ããã®çç©æŽ»æ§ã¿ã³ãã¯è³ªãç¹ã«
ããïœâPAã§ããããšãã§ããã°ãªã³ã·ã«åã
ãŠãã圢ããã³ã°ãªã³ã·ã«åããŠããªã圢ã®ãã®
ãå å«ãããããã¯EPââ112122ã«èšèŒãã
ãŠãããããªïŒé圢ãŸãã¯ïŒé圢ïœâPAã§ãã
ããšãã§ããå åã«ã°ãªã³ã·ã«åããŠããããïœ
âPAã®å Žåã«ãçŽ70000ã®ããªã¢ã¯ãªã«ã¢ããã²
ã«ã«ããšã¥ãèŠæãäžã®ååéããã³7.5ã8.0ã®
çé»ç¹ãæããã奜ãŸããã¯ãïœâPAã¯çŽ
500000IUïŒmgã®æ¯æŽ»æ§ãæãããIU.ïŒmgïŒåœé
åäœïŒmgïŒåœéåäœã¯WHOããã·ãšãã« ã€ã³
ã¹ãããŠãŒã ããªã¢ ãã€ãªããžã«ã« ã¹ã¿ã³
ããŒã ã¢ã³ã ã³ã³ãããŒã«ïŒNational
Institute for Biological Standards and
ControlïŒãããŒãªã€ ãã«ããã ãã¹ããããã
ã³ãã³ïŒHolly HillãHampsteadãLondonïŒ
NW ïŒ ïŒ RBãè±åœã«ããèŠå®ãããŠãããš
ããã®æŽ»æ§åäœã§ãããã ïœâPAã®ã¢ããé žé åã¯å¥œãŸããã¯ç¬¬ïŒå³ã«
èšèŒã®é åã«å®è³ªçã«çžåœãããããªãã¡ããã®
é åã¯ç¬¬ïŒå³ã®é åãšåäžã§ãããããŸãã¯å¯Ÿç«
圢質æºã§ãããã¯ãã®ä»ã®äžçš®ãŸãã¯äºçš®ä»¥äžã®
ã¢ããé žã®æ¬ èœã眮ãæããæ¿å ¥ã転äœãŸãã¯ä»
å ãå«ã¿ãçæããé åã¯ç¬¬ïŒå³ã®é åãšå°ãªã
ãšã80ïŒ ã奜ãŸããã¯90ïŒ ã®çžåæ§ãæãããã®
ã¿ã³ãã¯ã®åäžã®çç©åŠçããã³å ç«åŠçæ§è³ªã
åºæ¬çã«ä¿æããŠãããç¹ã«ãïœâPAé åã¯ç¬¬
ïŒå³ã®é åãšåäžã§ãããããããã¯ã»ãªã³ïŒ®â
æ«ç«¯ãã245çªç®ã®äœçœ®ã«ã¡ããªãã³ã®ä»£ãã«ã
ãªã³ãæãã以å€ã¯åäžé åãæãããããã©ã¡
ãã®é åãå Žåã«ãããæåã®ïŒåã®ã¢ããé žã«
ãã¥ãããååšããŠããªããããŸãã¯å Žåã«ãã
GlyâAlaâArgã®è¿œå ã®ããªããããâæ«ç«¯
å è¡é åãæããã 第ïŒå³ã«ç€ºãããŠããã¢ããé žé åã¯35ã®ã·ã¹
ãã€ã³æ®åºãæããåŸã€ãŠ17ã®ãžã¹ã«ãã€ãæ©ã
圢æããèœåãæãããæ§é ãããã«è©³çŽ°ã«æ±ºå®
ãããŠãããã®ä»ã®ã¿ã³ãã¯ãšã®åææ§ã«ããšã¥
ãã90çªç®ã®äœçœ®ã®ã¢ããé žãšãããªã³ïŒ£âæ«ç«¯
ãšã®éã®é åã«ã€ããŠã®ä»®å®æ§é ã第ïŒå³ã«ç€ºã
ããŠããã第ïŒå³ã«ãããŠãïŒå°ã¯ïŒé圢ïœâ
PAãäžããïŒé圢ïœâPAã®éè£éšäœã瀺ãïŒã
ãã§ïŒ¡éã¯ïŒã€ã®ç°ç¶ïŒKringleïŒé åãå«ã¿ã
ãããŠïŒ¢éã¯ã»ãªã³ãããã¢ãŒãŒé åãå«æã
ãããã®ïŒ®âæ«ç«¯é åã®æ§é ã¯ç¢ºå®ããŠããªã
ããããã€ãã®ææ¡ãæ瀺ãããŠãããããã°ã¬
ã¹ ã€ã³ ãã€ããªããªã·ã¹ïŒProgress in
FibrinolysisïŒã1983幎ãïŒã269ã273é ïŒãã
ã³ããã¯ïŒããã«ïŒã¢ã«ãïŒãµã€ïŒïŒProc.Natl.
Acad.Sci.ïŒ1984幎ã81ã5355ã5359é åç §ããïœ
âPAã®æ§é ã®æãéèŠãªç¹åŸŽã¯ãã®ã¿ã³ãã¯ã
ãã€ããªã³ã«çµåãã圹ç®ãã¯ãããŠããïŒã€ã®
ç°ç¶éšåïŒ92çªç®ã®ã¢ããé žãš173çªç®ã®ã¢ãã
é žã®éããã³180çªç®ã®ã¢ããé žãš261çªç®ã®ã¢ã
ãé žãšã®éïŒããã³ïŒ¢éã®äž»èŠé åãå«ãããšã
ãã³ããã©ã¹ãããŒã²ã³ã®æŽ»æ§åã®åœ¹ç®ãã¯ãã
ã»ãªã³ãããã¢ãŒãŒé åã«ãããã»ãªã³ãããã¢
ãŒãŒé åã«ãããç¹å¥ã«éèŠãªã¢ããé žã¯è§Šåªç
äžãçµã¢ããé žãHisïŒAspïŒSerã§ãããïœâ
PAã«ãããŠã¯ããããã¯322çªç®ã371çªç®ãã
ã³463çªç®ã«äœçœ®ããŠããã264çªç®ããã³395çª
ç®ã®ã·ã¹ãã€ã³ã¢ããé žæ®åºããŸãéèŠã§ããã
ãããã¯ïœâPAã®ïŒã€ã®é圢ã®ïŒ¡éãšïŒ¢éãšã
äžç·ã«ä¿æããŠããã 第ïŒå³ããã³ç¬¬ïŒå³ã«ãããŠãã¢ããé žæ®åºã«
ã€ããŠäžèšã®ãšããã®æ £çšã®ïŒåèšå·ããã³ïŒå
èšå·ã䜿çšããïŒ Asp  ã¢ã¹ãã©ã®ã³é ž Ile  ã€ãœãã€ã·
ã³ Thr  ã¹ã¬ãªãã³ Leu  ãã€ã·ã³ Ser  ã»ãªã³ Tyr  ããã·ã³ Glu  ã°ã«ã¿ãã³é ž Phe  ããšãã«ã¢ã©
ãã³ Pro  ãããªã³ His  ãã¹ããžã³ Gly  ã°ãªã·ã³ Lys  ãªãžã³ Ala  ã¢ã©ãã³ Arg  ã¢ã«ã®ãã³ Cys  ã·ã¹ãã€ã³ Trp  ããªãããã¢ã³ Val  ããªã³ Gln  ã°ã«ã¿ãã³ Met ïŒ ã¡ããªãã³ Asn  ã¢ã¹ãã©ã®ã³ ïœâPAã¯åœæè¡ã§æ¢ç¥ã®ãŸãã¯é瀺ãããŠã
ã補é æ¹æ³ã®ãã¥ããã«ããåŸãããšãã§ããã
äžäŸãšããŠãïœâPAã¯ãã€ãªããã« ãš ãã€
ãªãã€ã·ã« ã¢ã¯ã¿ïŒBiochimica et
Biophysica ActaïŒã1979幎ã580ã140ã153ïŒ
EPââ41 766ãŸãã¯EPââ113 319ã«èšèŒ
ãããŠããçš®é¡ã®æ£åžžãŸãã¯è «çã»ã«ã©ã€ã³ãã
åŸãããšãã§ãããããããªãããïœâPAã¯ã
ããšãã°EPââ93 619ïŒEPââ117 059ãŸ
ãã¯EPââ117 060ã«èšèŒãããŠãããããª
DNAçµæãææ³ãçšããŠèªå°ãããå¹é€ãã圢
質転æãŸãã¯ãã©ã³ã¹ããšã¯ã·ãšã³ãããã»ã«ã©
ã€ã³ããåŸããšå¥œãŸãããïœâPAã®è£œé ã«ãã€
ã€ããŒãºãã ã¹ã¿ãŒåµå·£ïŒCHOïŒçŽ°èã䜿çšãã
ã¢ã¬ããŠã©ãŒ ã¢ã³ã ã»ã«ã©ãŒãã€ãªããžã€
ïŒMolecular and Cellular BiologyïŒã1985幎ïŒ
(7)ã1750ã1759é ã«èšèŒã®æ¹æ³ã§èªå°ãããšç¹ã«
奜ãŸããããã®æ¹æ³ã§ãã¯ããŒã³åãããéºäŒå
ããžãããããªã¬ãŒãã¬ãã¯ã¿ãŒãŒïŒdhfrïŒã
dhfrâCHO现èã«ã³ãŒãããéºäŒåã«ããã³ã
ã©ã³ã¹ããšã¯ã·ãšã³ãããã圢質転æäœãçºçŸã
ãdhfrã¯ãã¯ã¬ãªã·ãäžå«å¹å°ã§éžæãããå¢å
ããæ¿åºŠã®ã¡ããã¬ãã»ãŒãã«ãããããããã
ããŠãdhfrããã³ïœâPAéºäŒåã¯å ±ã«å¢å¹ ãã
ãŠãé«ã¬ãã«ã®ïœâPAãçºçŸããããšãã§ãã
å®å®ãªã»ã«ã©ã€ã³ãå°ãã ïœâPAã¯å¥œãŸããã¯ãäžèšã®æç®ã«èšèŒãã
ãŠãããããªåœæè¡ã§æ¢ç¥ã®ãŸãã¯é瀺ãããŠã
ãæ¹æ³ã®ãã¥ãããçšããŠç²Ÿè£œããïŒãã€ãªã±ã
ã« ãš ãã€ãªãã€ãžã« ã¢ã¯ã¿
ïŒBiochimicaet Biophysica ActaïŒã1979幎ã
580ã140ã153é ïŒãžã€ãŒãã« ãªã ãã€ãªã
ãžã«ã« ã±ãã¹ããªã€ïŒJ.Biol.Chem.ïŒã1979幎ã
254(6)ã1998ã2003é ïŒåã1981幎ã256ïŒ13ïŒã
7035ã7041é ïŒãšãŒããã ãžã€ãŒãã« ãªã
ãã€ãªã±ãã¹ããªã€ïŒEur.J.Biochem.ïŒã1983
幎ã132ã681ã686é ïŒEPââ41 766ïŒEPâ
â113 319ïŒãŸãã¯GBââïŒ 122 219ã æ¬çºæã®æ¹æ³ã§äœ¿çšããïœâPAã®æ°Žæº¶æ¶²äžã«
ããã溶解床ã«ã¯ãã¥ããã®äžéãååšãããã
ã«ã¯ã¿ããªãã150000000IU.ïŒmlïŒåœéåäœïŒ
mlïŒãã倧ãããããªæ¥µããŠé«ãæ¿åºŠã§ãã溶液
ã¯ãã¥ãã®ææã®ïœâPAæ²æ®¿ããšããªãããšãª
ãåã«ç²æ§ã«ãªãã ãã§ãããåŸã€ãŠã氎溶液äž
ã«ãããïœâPAã®æ¿åºŠã¯åºãéçå ãããšãã°
50000ã50000000IUïŒmlã§å€ããããšãã§ããã
æ¬çºæããæé«ã®å©çã確ä¿ããããã«ã¯ãïœâ
PAã®æ¿åºŠã¯100000IUïŒmlãã倧ãããã«ç¹ã«
500000IUïŒmlãã倧ãããã«ç¹ã«1000000IUïŒml
ãã倧ã§ãããïœâPAã®æ¿åºŠãçŽ5000000IUïŒ
mlã§ãããšæé«ã«å¥œãŸããã 氎溶液ã®PHã®äžéã¯å¥œãŸããã¯4.5ã§ãããå®
éã«ããã®PHã¯å¥œãŸããã¯2.5ã4.0ã®ç¯å²ããã
ã«å¥œãŸããã¯2.8ã3.5ã®ç¯å²ãããã«ç¹ã«å¥œãŸã
ãã¯çŽ3.0ã§ããã氎溶液ã®ææã®PHã¯ççåŠç
ã«èš±å®¹ããããç¡æ©ãŸãã¯ææ©é žãçšããŠåŸããš
簡䟿ã§ããããã®ãããªé žã®äŸã«ã¯å¡©é žãç¡«é žã
ãã³ç¡é žã䞊ã³ã«ã¯ãšã³é žãé ç³é žããã³ãã³ãŒ
ã³ã¹ã«ãã³é žãå å«ãããããããã®äŸã®äžã§å¡©
é žã奜é©ã§ããã æãçš®ã®ççåŠçã«èš±å®¹ããããå ±æº¶å€ãæ°Žã«
å ããŠå Žåã«ããååšãããããšãã§ããããæ°Ž
溶液çšã®åªè³ªã¯å šäœçã«ãããã¯å®è³ªçã«æ°Žæ§ã§
ãããšå¥œãŸããã åçµä¹Ÿç¥å»è¬è£œå€ããåŸãããéçµè žæäžçšæº¶
液ã¯æ£è ã®è¡æž ãšé匵ãäœåŒµãŸãã¯ç匵ã§ããã
ãšãã§ãããããããªãããæãŸãããªãå¯äœçš
ãåé¿ããããã«ãéçµè žæäžçšæº¶æ¶²ã¯ç匵ã§ã
ããšå¥œãŸãããäœåºŠã®å€åã¯ççåŠçã«ããŸãé¢
ä¿ã¯ãªããå®è³ªçã«ç匵æ§ã®éçµè žæäžçšæº¶æ¶²ã¯
溶液ã®åŒµåºŠãèŠæ±ãããã¬ãã«ã«äžæãããããš
ãã§ããççåŠçã«èš±å®¹ããããå©å€ãå«ãŸãã
ããšã«ããåŸãããšãã§ããããã®ãããªå©å€ã¯
åçµä¹Ÿç¥å»è¬è£œå€äžã«ãã§ã«ååšããããã«åçµ
也ç¥ããã氎溶液ã®äžã«å«ãŸããããšãã§ããã
ããã¯ææã®éçµè žæäžçšæº¶æ¶²ãåŸãããã«ãã®
ãããªè£œå€ã溶解ããããã«çšããããäžæ§ãŸã
ã¯é žæ§PHã®æ°Žã®äžã«å«æãããããšãã§ãããã
ã®ãããªå©å€ã®äŸã¯åœæè¡ã§ããç¥ãããŠããã
ããã¹ãããŒã¹ïŒç¡æ°Žç©åœ¢ãŸãã¯äžæ°Žåç©åœ¢ïŒã
ãã³å¡©åãããªãŠã ããã³ãŸããã®æ··åç©ãå å«
ããã氎溶液ãŸãã¯æº¶è§£çšæ°Žäžã®ãã®ãããªå©å€
ã®æ¿åºŠã¯äœ¿çšããç©è³ªã«ããå€ããããšã¯å¿è«ã®
ããšã§ãããå¡©åãããªãŠã ã®å Žåã«ããã®æ¿åºŠ
ã¯å¥œãŸããã¯ïŒã10mgïŒmlãããã«å¥œãŸããã¯çŽ
8.5mgïŒmlã§ããããã®æ¿åºŠã¯ãã°ãã°ççé£å¡©
液ãŸãã¯ççé£å¡©æ°Žãšç§°ãããæ¿åºŠã§ãããç¡æ°Ž
ããã¹ãããŒã¹ã®å Žåã«ããã®æ¿åºŠã¯å¥œãŸããã¯
30ã70mgïŒmlãããã«å¥œãŸããã¯çŽ50mgïŒmlã§ã
ãã 氎溶液ã¯å Žåã«ãããã®çš®ã®åçµä¹Ÿç¥å»è¬è£œå€
ãéåžžå«æããæ·»å å€ãå«æã§ããããã®ãããª
äŸãšããŠã¯ããè¡æž ã¢ã«ããã³ãçµåå€ãããã
ããŒã«ãä¹³ç³ããã³ã°ã«ã³ãŒã¹ã®ãããªå å¡«å€ã
å å«ãããããã«ãïœâPAã¯ã¬ã©ã¹ããã³ãã©
ã¹ããã¯è¡šé¢ã«åžçããåŸåããããåŸã€ãŠãã®
ãããªåžçãé²æ¢ãããããŸãã¯æäœã«ãããã
ã«ã氎溶液äžã«è¡šé¢æŽ»æ§å€ãå«æãããããšãæ
ãŸããããšãããããã®ãããªè¡šé¢æŽ»æ§å€ã®äŸã«
ã¯ããã€ãŒã³80ãïŒTween80ïŒã®åååã§åžè²©ã
ããŠãããããªç¡æ°Žãœã«ãããŒã«ã®èèªé žéšåãš
ã¹ãã«ã®ããªãªãã·ãšãã¬ã³èªå°äœãå«ãŸããã æ¬çºæã®é©ãã¹ãå©ç¹ã®äžã€ãšããŠã¯ãïœâ
PAã®å®è³ªçã«å¢å€§ãã溶解床ã¯å¥ã«ããŠãåçµ
也ç¥å»è¬è£œå€ã®åæ§æã«ããåŸãããé žæ§éçµè ž
æäžçšæº¶æ¶²ã®äœ¿çšãæ£è ã«æäžããæã«ãã¥ãã
ææã®æ害ãªççåŠçäœçšã瀺ããªãããšã«ã
ããè¡æµã¯äžè¬ã«ã溶液ã®PHãæ¥è§Šããã»ãšãã©
ããã«äžæ§ã«äžæãããããã«èŠããïœâPAã¯
è¿ éã«è¡æµå ã«ååžããããããããªããããã®
æ¹æ³ã¯ãã¥ãã®æ¹æ³ã§ãå®è³ªçã«åŠšå®³ãããªãã
ãšããã³ãã®éçµè žæäžçšæº¶æ¶²ããã³åçµä¹Ÿç¥ã
ãã氎溶液ããã³ãŸãåæ§æçšã®æ°Žã¯åŒ·åãªç·©è¡
å€ãå«æããªãããšã奜ãŸããããããããã®æ¹
æ³ãææã«é»å®³ããªã匱ãç·©è¡å€ã¯å«ãŸããŠãã
ããé žæ§PHã§ïœâPAããèªäœãããèªäœã§åŒ±ã
ç·©è¡å€ãšããŠäœçšããããšã確ãã§ãããããã«
ãŸããããè¡æž ã¢ã«ããã³ã¯åŒ±ãç·©è¡å€ãšããŠäœ
çšã§ããã ïœâPAãïŒãïŒã®PHã®æ°Žæº¶æ¶²äžã§å®è³ªçã«å¢
倧ãã溶解床ãæããããšããããã®åçµä¹Ÿç¥è£œ
å€ã®åæ§æããåŸãããéçµè žæäžçšæº¶æ¶²ã«ã¯ïœ
âPAã®æº¶è§£åºŠãå¢åŒ·ããããã®ãªãžã³ãŸãã¯ãª
ã«ããã³ãããã¯ãã®æ··åç©ã®ãããªãã¥ããè¿œ
å ã®å©å€ãå«æãããå¿ èŠã¯ãªãã ïœâPAã®æ°Žæº¶æ¶²ã¯ç²Ÿè£œããïœâPAã®æº¶æ¶²ã
åŸã次ãã§ïŒãïŒã®PHãæããæ°Žæ§åªè³ªçšã¡ãžãŠ
ã ãšäº€æããããšã«ããããããã¯ç²Ÿè£œããïœâ
PAãïŒãïŒã®PHãæããæ°Žæ§ã¡ãžãŠã äžã«æº¶è§£
ããããšã«ãã調補ã§ããã ïœâPAã®ç²Ÿè£œã¯ã¯ãããã°ã©ãã€ã«ã©ã ãã
匷åãªç·©è¡å€ãå«æãã溶液ãšããŠã¿ã³ãã¯ã溶
é¢ããå·¥çšãæçµå·¥çšãšããŠå«ãããšãã§ããã
åèšããããã«ãéçµè žæäžçšæº¶æ¶²ããã³åŸã€ãŠ
åçµä¹Ÿç¥å»è¬è£œå€ããã³æ°Žæº¶æ¶²ã¯åŒ·åãªç·©è¡æå€
ãå«æããŠããªããåŸã€ãŠããã®é€å»ãè¡ãªãç°¡
䟿ãªæ段ãšããŠã¡ãžãŠã ã®äº€æã«éæã䜿çšãã¹
ãã§ãããéæã¯ç²Ÿè£œæº¶æ¶²ãïŒãïŒã®PHãæãã
æ°Žæ§ã¡ãžãŠã ã«å¯ŸããŠéæãããéæ管ãŸãã¯äºº
å·¥è èãçšããŠå®æœã§ãããç¹ã«ç²Ÿè£œæº¶æ¶²äžã®ïœ
âPAã®æ¿åºŠãé«ãå Žåã«ã¯ãå ããã®æº¶æ¶²ã®PH
ãïŒãïŒã«èª¿è£œããããšãæãŸããããšãããã
匷åãªç·©è¡å€ãé€å»ãããšãšãã«ã¡ãžãŠã ã亀æ
ããããã®ããäžã€ã®æ段ã¯ç²Ÿè£œæº¶æ¶²ãã²ã«æ¿Ÿé
ãã次ãã§ïŒãïŒã®PHãæããæ°Žæ§ã¡ãžãŠã ã§ã«
ã©ã ãå±éããæ¹æ³ã§ããã æ²æ®¿ããåºäœã®åœ¢ã®ïœâPAã¯å¥œãŸããã¯ç²Ÿè£œ
溶液ãããã®PHãçŽ5.5ã«èª¿è£œãã溶液ããã®å
çµç¹ã®ããäžã®æž©åºŠãŸã§å·åŽãã次ãã§ããšãã°
é å¿åé¢ã«ããã¿ã³ãã¯ãåãåºãããšã«ããåŸ
ãããšãã§ãããæ²æ®¿ããåºäœã¯æ¬¡ãã§ïŒãïŒã®
PHãæããæ°Žæ§åªè³ªäžã«åžžæ³ã«ãã溶解ã§ããã çæãã氎溶液ã¯éœåè¯ããããšãã°æ¿Ÿé殺è
ã«ãã殺èããããã³æ¬¡ãã§ã¢ã³ãã«ãŸãã¯ãã€
ã¢ã«ã®ãããªç¡èãã©ã¹ããã¯ãŸãã¯ã¬ã©ã¹å®¹åš
ã«ãããšãã°0.5ã20mlã®å®¹éã§åé ããã ïœâPAã®æ°Žæº¶æ¶²ã¯ã奜ãŸããã¯â10ãâ40â
ã®æž©åºŠã§å·åãããå·åãã氎溶液ã¯æ¬¡ãã§ã奜
ãŸããã¯ãã®æž©åºŠã«ç空也ç¥ãéå§ãããŸã§ä¿æ
ããã å·åãã氎溶液ã®ç空也ç¥ã¯é©å®ã«å®æœã§ãã
ããšãã°0.01ã0.1ããŒã«ã§å®è³ªçã«å šãŠã®å·å
液ã®é€å»ãè¡ãªããããŸã§å åãªæéãéšåçç
空ãŸãã¯å®å šç空äžã«ä¹Ÿç¥ãããããšãå å«ã
ãã ç空也ç¥ãè¡ãªã枩床ã¯éåžžã氎溶液ãå®è³ªç
ã«ãŸãã¯å®å šã«åçµãã圢ã§ç¶æãããããã«ã
åŠçã®éå§æç¹ã§â30ãâ40âã§ãããåŠçœ®ãé²
è¡ããæ°Žãé€å»ãããã«ã€ããŠã枩床ã¯å®€æž©ã«é
ãããŸã§æ¬¡ç¬¬ã«äžæããããšããããæåŸã®çè·¡
éã®æ°Žãã§ããã ãé€å»ããããã«ãåŠçã®çµäº
æç¹ã«ãããŠå®€æž©ãŸãã¯ãã®ããäžæž©åºŠã§çŽ0.01
ããŒã«ã®å®è³ªçç空äžã«ç空也ç¥ãè¡ãªããšå¥œãŸ
ãããçæããåçµä¹Ÿç¥å»è¬è£œå€ã®æ°Žå«æéã¯å¥œ
ãŸããã¯2.5ïŒ ä»¥äžã§ãããç空也ç¥ãå®äºãã
ãªãã°ãåçµä¹Ÿç¥ãããå»è¬è£œå€ãå«æããç¡è
ã®ãã©ã¹ããã¯ãŸãã¯ã¬ã©ã¹å®¹åšãéœåè¯ãå¯å°
ããã å·åãã氎溶液ã®ç空也ç¥äžã«ãæ°Žãé€å»ã
ããïœâPAãççåŠçã«èš±å®¹ããããå¡©ã®åœ¢ã§
æ®ããåŸã€ãŠãæ¬çºæã¯ãŸãïœâPAã®ççåŠç
ã«èš±å®¹ããããå¡©ãç¹ã«å¡©é žå¡©ã®ãããªççåŠç
ã«èš±å®¹ããããé žä»å å¡©ãæäŸããã æ¬çºæã䜿çšããããšã«ããé«æ¿åºŠã§ïœâPA
ãå«æããéçµè žæäžçšæº¶æ¶²ãæäŸã§ããåçµä¹Ÿ
ç¥å»è¬è£œå€ãæåã«åŸãããšãã§ãããåŸã€ãŠã
æ¬çºæã¯ãŸãæ°Žãå ãããšïœâPAã100000IUïŒ
mlãã倧ã®ãããã«ç¹ã«500000IUïŒmlãã倧ã®ã
æãç¹å¥ã«1000000IUïŒmlãã倧ã®æ¿åºŠã§æäŸã
ãããšãã§ããïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ãæ
äŸããã æäžçšã®ïœâPAã®éçµè žæäžæº¶æ¶²ã調補ãã
ã«ã¯ãæ¬çºæã®æ¹æ³ã«ããåŸãããåçµä¹Ÿç¥å»è¬
補å€ãäžæ§ãŸãã¯é žæ§PHã®æ°Žã§åæ§æãããåçµ
也ç¥å»è¬è£œå€ãåŸããã氎溶液ãå®è³ªçã«ç匵ã§
ããå Žåã«ãåæ§æçšã®æ°Žã¯ãŸãå®è³ªçã«åŒµçã§
ãããšå¥œãŸããã è¡å¡ã®ãã€ããªã³ç¶²ç¶æ§é ã溶解ããéã®ïœâ
PAã®çç©åŠç掻æ§ã¯è¡æ æ§é害ã®åŠçã«ããã
ãã®äœ¿çšãå°ããŠããã㶠ã©ã³ã»ããïŒThe
LancetïŒã1981幎11æïŒæ¥ã1018ã1020é ïŒ1985
幎ïŒæ13æ¥ã842ã847é ïŒã¶ ããŠãŒ ã€ã³ã°ã©
ã³ã ãžã€ãŒãã« ãªã ã¡ãã€ã·ã³ïŒThe
New England Journal of MedicineïŒã1984幎ã
310(10)ã609ã613é ïŒåã1985幎ã312ïŒ14ïŒã932
ã936é ããåŸã€ãŠãæ¬çºæã¯åºä¹³åç©ã«ãããè¡
æ æ§é害ã®åŠçœ®æ¹æ³ãæäŸãããã®æ¹æ³ã¯åèšå®
矩ã®ãšããã®åçµä¹Ÿç¥å»è¬è£œå€ããåŸãããïœâ
PAã®éçµè žæäžçšæº¶æ¶²ãåºä¹³åç©ã«æäžããã
ãšãå«ãã§ãããå¥æ§ã«ã¯ããããŸãã¯åç©ã«äœ¿
çšãããç¹ã«è¡æ æ§é害ã®åŠçœ®ã«äœ¿çšããããã®
ïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ãæäŸããã è¡æ æ§é害ã®ç¹å®ã®äŸã¯åœæ¥è ã«ç¥ãããŠãã
ããå¿çæ¢å¡ãæ·±åèè¡æ çãèºå¡æ çããã³å
äžãå å«ããã ïœâPAã®äž»èŠæäžçµè·¯ã¯è¡ç®¡å ãç¹ã«éèå
æ³šå ¥ã«ããããèãããããã®ä»ã®æäžçµè·¯ãã
ãšãã°çèå æäžã䜿çšã§ãããè¡ç®¡å æ³šå ¥ã¯é
åžžãæ³šå ¥çšè¢ãŸãã¯ãã³å ã«ãããã¯é»æ°çã«æ
äœãããæ³šå ¥ã·ãªã³ãå ã«å«æãããŠããéçµè ž
æäžçšæº¶æ¶²ãçšããŠè¡ãªãããã®æº¶æ¶²ã¯æ³šå ¥è¢ãŸ
ãã¯ãã³ããæ£è ã«éåäŸçµŠã«ããããŸãã¯æ³šå ¥
ãã³ãã䜿çšããããšã«ããäžããããšãã§ã
ããééäŸçµŠæ³šå ¥ã·ã¹ãã ã䜿çšãããšãéçµè ž
æäžçšæº¶æ¶²ã®æäžé床ãç·äœçã«å åã«å¶åŸ¡ããŠ
äŸçµŠã§ããªããåŸã€ãŠãæ³šå ¥ãã³ãã®äœ¿çšãæ¯èŒ
çé«æ¿åºŠã®ïœâPAãå«æãã溶液ã®å Žåã«ç¹ã«
奜é©ã§ãããããããªãããããã«å¥œãŸããã¯ã
æäžé床ãç·äœçã«ãã倧ããå¶åŸ¡ã§ããé»æ°ç
ã«æäœããæ³šå ¥ã·ãªã³ãžã䜿çšããã è¡æ æ§é害ãæã€åºä¹³åç©ã®åŠçœ®ã«æå¹ãªïœâ
PAã®éã¯å€ãã®å åãããšãã°åºä¹³åç©ã®å¹Žä»€
ããã³äœéãåŠçœ®ãå¿ èŠãšããæ£ç¢ºãªçç¶ããã³
ãã®é節床ãæäžçµè·¯ãå«ãå åã«äŸåããŠå€ã
ãããšã¯å¿è«ã§ããã究極çã«ã¯äž»æ²»å»ãŸãã¯äž»
æ²»ç£å»ã®è£éã§ãããããããªãããããšãã°å
ç¶åèè¡æ ã溶解ãããæå¹éã¯äžè¬ã«150000ã
450000IUïŒæ£è ã®äœéKgïŒæã®ç¯å²ã§ãããšå¥œ
ãŸãããåŸã€ãŠãäœé70Kgã®æ人ã®å Žåã«ãïŒæ
éåœãã®æå¹éã¯äžè¬ã«10000000ã30000000IUã
ç¹ã«çŽ20000000IUã§ããããã®éã¯ååéãçš
ããŠãŸãã¯çšããããšãªãæäžã§ãããããã«ã
ãã®æäžéã¯ããã€ãã®è¡æ çç¶ãããšãã°æ·±å
èè¡æ çããã³æ¥æ§åäžã®ãããªçç¶ã«å¯ŸããŠ
ã¯ããŸãã¯ãã§ã«åæœ æµãããŠããå ç¶åèã®é
æŸæ§ãåçŽã«ç¶æããããã®å Žåã«ã¯ããã«å°é
ã«ãããšå¥œãŸããããããã®å Žåã«ãæå¹éã¯äž
è¬ã«7000ã36000IUïŒæ£è ã®äœéKgïŒæã§ããã 次äŸã¯æ¬çºæãäŸç€ºããããã«ç€ºããã®ã§ãã€
ãŠãæ¬çºæããã¥ãã®ç¹ã§ãå¶éããããšããã
ã®ã§ã¯ãªãã äŸ ïŒ ã¢ã¬ããŠã©ãŒ ã¢ã³ã ã»ã«ã©ãŒ ãã€ãªããž
ã€ïŒMolecular and Cellular BiologyïŒã1985
幎ãïŒ(7)ã1750ã1759é ã®æ¹æ³ã䜿çšããŠèªå°ã
ããå¹é€ãã圢æ転æãããCHOã»ã«ã©ã€ã³ã
ãåŸãããïœâPAã®æž æµã«ããåç©«ç©ãã¯ãã
ãã°ã©ãã€ã«ãã粟補ããïœâPAã0.17Mã¯ãš
ã³é žãããªãŠã ããã³0.01ïŒ ïŒééïŒå®¹éïŒãã€
ãŒã³ïŒïŒãå«æããPH5.5ã®æ°Žæº¶æ¶²ãšããŠæ¡åã
ãã溶液ã®PHãå¡©é žã§3.0ã«èª¿æŽããçæãã溶
液ãâ10ã«ãŒããªããžïŒCartridgeïŒãã¢ãã³ã³
瀟ïŒAmicon Ltd.ïŒã¢ãã㌠ãã«ãã¹ããŒã³
ããŠã¹ãã°ãã»ã¹ã¿ãŒã·ã€ãŒïŒUpper Hillã
StonehouseãGloucestershireïŒãè±åœããçšããŠ
é å¿åé¢ã«ããæ¿çž®ãããæ¿çž®ãã氎溶液ãã²ã«
æ¿Ÿéã«ã©ã ãã»ãã¢ããã¯ã¹ïŒSephadexïŒïŒ§â
150ïŒãã¢ãŒãã·ã¢ ãã€ãªãã¯ãããžã€ç€Ÿ
ïŒPharmacia BiotechnologyïŒãã¢ãããµã©ãã¹
ãšãŒãã³ïŒUppsalaãSwedenïŒãã«é©çšãã0.01
ïŒ ïŒééïŒå®¹éïŒãã€ãŒã³ïŒïŒãå«æãã0.85ïŒ
å¡©é¡æº¶æ¶²ã§3.0ã®PHã«ãããŠæº¶åºããããšã«ãã
ããã«ç²Ÿè£œããããã®ããã«ããŠåŸãããé«åºŠã«
粟補ãããïœâPAã®æ°Žæº¶æ¶²ã䜿ãæšãŠäººå·¥è è
ãçšããŠããäžåºŠæ¿çž®ãããïœâPAã¯PHãæ°Žé ž
åãããªãŠã ã§5.5ã«å¢å€§ãã次ãã§æžæ¿æ¶²ãïŒ
âã§ïŒæéä¿æããããšã«ãã溶液ããæ²æ®¿ãã
ãããã®æº¶æ¶²ãïŒâã§30åéã4000Ãïœã§é å¿å
é¢ããæ²æ®¿äžã«å šéšã§1680Ã106åäœã®ïœâPAã
æ¡åããããã®ïœâPAãã¬ãããã0.01ïŒ ïŒé
éïŒå®¹éïŒã®ãã€ãŒã³ïŒïŒãå«æããå¡©åãããª
ãŠã ã®æ°Žæº¶æ¶²ã0.85ïŒ ïŒééïŒå®¹éïŒã2300ml
ïŒ7500000IUïŒmlã10000000IUïŒmlã®æ¿åºŠããã
ã«å¿ èŠãªéïŒäžã«å溶解ããå¡©é žã§PH3.0ã«èª¿æŽ
ããããã®å溶解ããïœâPAãã¬ããã«ã€ããŠ
ïœâPA掻æ§ãç¹°è¿ã枬å®ãã8.09Ã106IUïŒmlã®
ïœâPA掻æ§ãåŸãããã®ïœâPAã®æº¶æ¶²ãã0.01
ïŒ ïŒééïŒå®¹éïŒã®ãã€ãŒã³ïŒïŒãå«æããå¡©å
ãããªãŠã ã®æ°Žæº¶æ¶²ã0.85ïŒ ïŒééïŒå®¹éïŒã490
mlã§ããã«åžéããå¡©é žã§PH3.0ã«èª¿æŽãã次ã
ã§åäžé žæ§å¡©é¡æº¶æ¶²äžã®10ïŒ ïŒééïŒå®¹éïŒãã³
ãããŒã«æº¶æ¶²930mlã§åžéãããããã«ãã€ãŠã
ïœâPA5000000IUïŒmlããã³ãã³ãããŒã«25
mgïŒmlãå«æãã溶液3720mlãåŸããçæãã溶
液ããã€ã«ã¿ãŒæ®ºèãã次ãã§ã¬ã©ã¹ãã€ã¢ã«äž
ã«ïŒmlã®å®¹éã§åé ãããã€ã¢ã«ãâ35âã§å·å
ããã0.05ããŒã«ã§æžå§ãé©çšãããçŽ24æéåŸ
ã«ã枩床ãåŸã ã«ïŒâã«äžæããããã®æž©åºŠã§16
æéä¿è·ããã次ãã§ãå床25âã«äžæãããæž
å§ã0.02ããŒã«ã«ããã«24æéå¢å€§ãããã®åŸã
ã€ã¢ã«ã也ç¥çªçŽ ã®600ããŒã«ã®éšåæžå§äžã«å¯
å°ããã äŸ ïŒ äŸïŒã®ïœâPAã®åçµä¹Ÿç¥è£œå€ããåŸãããé
çµå£æäžçšæº¶æ¶²ã®è¡æ 溶解å¹æãé éèè¡æ ã®ã€
ã³ããã¢ãã«ã§è©äŸ¡ããã (a) æ¹æ³ å®éšæ¹æ³ã¯ã³ã¬ã³ïŒCollenïŒä»ã«ããæåã«
èšèŒãããæ¹æ³ããžãšã€ïŒã¯ãªã³ïŒã€ã³ãã¹
ãïŒïŒJ.Clin.Invest.ïŒã1983幎ã71ã368ã376
é ãã«åºæ¬çã«åŸãã äŸïŒã®åçµä¹Ÿç¥è£œå€ãã0.01ïŒ ãã€ãŒã³ïŒïŒ
ãå«æããPH3.0ã«èª¿æŽããç¡èã®ç匵塩é¡æº¶
液ã«è¿ éã«ãå®å šã«æº¶è§£ããããã®åæ§æãã
ããïœâPAã®æ¿åºŠã¯50000IUïŒmlã§ãããã
ãããŠã500000IUïŒKgã®ïœâPAãïŒæéæ³šå ¥
ããããã®éçµå£æäžçšæº¶æ¶²ãåŸããããæ³šå ¥
ã¯å³å€§è ¿éšéèã§ã«ããŠãŒã¬ãçšããŠè¡ãªãã
ïŒå¹ã®ããŠãŒãžãŒã©ã³ãçœãŠãµã®ããã®å®éšã«
䜿çšãããæ³šå ¥åŸã«ãè¡æ 溶解ã®çšåºŠãè©äŸ¡ã
ãã (b) çµæ äŸïŒã®åçµä¹Ÿç¥è£œå€ããåŸãããéçµå£æäž
çšæº¶æ¶²ã®è¡æ 溶解å¹æã¯è¡æ æº¶è§£ïŒ ã§è¡šãããŠ
28.9±4.1ã§ãããããã«ããã®æº¶æ¶²ã«ããæ
害ãªåå¿ã¯èŠãããªãã
ã«çµç¹ãã©ã¹ãããŒã²ã³æŽ»æ§åå åãå«æããå»
è¬çµæç©ããããã®è£œé ããã³ãããã®ãããã
ã³åç©å»çã«ããã䜿çšã«é¢ããã è¡å¡ã圢æã§ããé µçŽ ç³»âåè¡ç³»âãšè¡å¡ã溶
解ã§ããé µçŽ ç³»âãã€ããªã³æº¶è§£ç³»ãšã®éã®å¥å š
ãªéæŸç¶è¡ç®¡åºãç¶æããŠããåçåè¡¡ãããã
ã®ãšèããããŠãããæå·ããã®å€±è¡ãå¶éãã
ããã«ãæå·ããè¡ç®¡ã«ã¯è¡å¡ã圢æããããæ
å·ãèªç¶ã«å埩ãããåŸã«ãäœåã®è¡å¡ã¯ãã€ã
ãªã³æº¶è§£ç³»ã®äœåã«ãã溶解ããããæã«ã¯ãè¡
å¡ãå€å·ããšããªãããšãªã圢æãããããã¯äž»
èŠè¡ç®¡ã«ãšã©ãŸãããšããããè¡æµãéšåçã«ãŸ
ãã¯å šäœçã«ãããéå¡ããçµæããããããã
ããå¿èãèºãŸãã¯è³ã§çãããšãå¿çæ¢å¡ãèº
å¯æ çãŸãã¯åäžãçºçãããããšãããããã
ãã®çµåãçç¶ã¯å·¥æ¥åœã«ããã眹ç çããã³æ»
亡çã®äž»èŠå ã§ããã è¡å¡ã¯ã¿ã³ãã¯åè§£é µçŽ ãã©ã¹ãã³ã«ãã溶解
ããããç¹ç¶ç¶²ç¶æ§é ãããªãããã®é µçŽ ã¯äžæŽ»
æ§ãªããé µçŽ ãã©ã¹ãããŒã²ã³ïŒããã¯è¡æŒ¿ã®æ
åã§ããïŒãããã©ã¹ãããŒã²ã³æŽ»æ§åå åã®äœ
çšã«ããèªå°ããããïŒçš®ã®å ç«åŠçã«ç°ãªãåº
ä¹³åç©ãã©ã¹ãããŒã²ã³æŽ»æ§åå åãååšããã
ãŠããããŒãŒãšããŠãç¥ãããŠããå åšæ§ãã©ã¹
ãããŒã²ã³æŽ»æ§åå åã¯è èã«ããç£çãããé µ
çŽ ã§ãããå°¿ããåé¢ã§ãããããã¯ãŸãå€ãã®
çµç¹å¹é€æºãããçæã§ãããè¡ç®¡ãã©ã¹ãããŒ
ã²ã³æŽ»æ§åå åãšããŠããã³çµç¹ãã©ã¹ãããŒã²
ã³æŽ»æ§åå åïŒïœâPAïŒãšããŠãç¥ãããŠãã
å€åšæ§ãã©ã¹ãããŒã²ã³æŽ»æ§åå åã¯ããªãã®çµ
ç¹ãã¢ãžããŒãïŒç¹ã«ããåå®®ïŒãè¡ç®¡çŽ°èå£ã
ãã³ããã€ãã®çŽ°èå¹é€ç©ããåé¢ã§ããããã
ãã®ïŒçš®ã®ãã©ã¹ãããŒã²ã³æŽ»æ§åå åã«å ã
ãŠãããŒã¿ãŒâè¡æ¶²æº¶è§£æ§ã¹ãã¬ããã³ãã·
ïŒstreptococciïŒããçæããã现èçæç©ãã¹
ãã¬ãããããŒãŒãããããŠããããŒãŒããã³ã¹
ãã¬ãããããŒãŒã®äž¡æ¹ãä»éããäž»èŠãªæ¬ ç¹ã¯
ãããã埪ç°åšç³»å šäœã«æŽ»æ§ã§ãããè¡å¡ã®éšäœ
ã§ã ã掻æ§ã§ã¯ãªãããšã«ããããããã¯ãããš
ãã°ãã€ããªããŒã²ã³ãããããã³ãã³ããã¢ã¯
ã¿ãŒïŒ¶ããã³ãã¢ã¯ã¿ãŒã®ãããªãã®ä»ã®è¡æ¶²
ã¿ã³ãã¯ãç Žå£ããããããŠè¡å¡åœ¢æèœåãæžã
ããã³åºè¡ã®å±éºãå¢å€§ããããããã«å¯ŸããŠã
ïœâPAã®çç©åŠç掻æ§ã¯ïœâPAãçµåããŠã
ããããã掻æ§åããããã€ããªã³ã®ååšã«äŸå
ãããããããŠãæ倧掻æ§ãè¡å¡ã®å Žæãããªã
ã¡æº¶è§£ããããšãããã€ããªã³ç¶²ç¶æ§é ã®ååšã
ãå Žæã§ã ãçããããã¯åºè¡ã®å±éºãæ Œå¥ã«å
é¿ãããã ïœâPAæäžã®äž»èŠçµè·¯ã¯è¡ç®¡å æ³šå ¥ã§ããã
åŸã€ãŠéçµè žæäžçšæº¶æ¶²ãšããŠãïœâPAã®è£œå€
ãèŠæ±ããããã¿ã³ãã¯è³ªã®å Žåãå»åž«ãŸãã¯ç£
å»åž«ã«è¬åãåçµä¹Ÿç¥å»è¬çµæç©ãšããŠæäŸãã
ããšã奜ãŸãããããã¯æ¶²äœè£œå€ã«ãŸãããã®æ
æã®ç§»éããã³è²¯èµé·æã«ãããã®ã§ããããã
ããªããããã¥ãã®ãã®ãããªåçµä¹Ÿç¥è£œå€ãäž
åœã«äžäŸ¿ã§å°é£ãªåé¡ãä»éããããšãªãææã®
éçµè žæäžçšæº¶æ¶²ã«å®¹æã«å€æã§ããããã³å»åž«
ãŸãã¯ç£å»åž«ããã®è£œå€ã滎éã®æº¶å€äžã§åæ§æ
ããããšã«ããåçŽã«ãã¥ããæå®ã®ç¶æ³ã«èŠæ±
ãããæ¿åºŠãåŸãããšãã§ããããšãéèŠã§ã
ããããšãã°ãå¿èãŸãã¯è èã®é害ãæããæ£
è ã«å€§éã®æº¶æ¶²ãæäžããããšã¯ãæ£è ã®å¿èãŸ
ãã¯è èã«ãã倧ããããšããããã¹ãã¬ã¹ãäž
ããããšããæãŸãããªããåŸã€ãŠãæäžå®¹éã¯
ãã®ãããªç¶æ³ã§æäœã«ç¶æãããã¹ãã§ããã
åŸã€ãŠãéçµè žæäžçšæº¶æ¶²ã¯æ¯èŒçäœæ¿åºŠã§ãã
ã°ããã§ãªãããŸãé«ãè¬ç©æ¿åºŠãæãããã®ãš
ããŠåŸãããšãã§ããããšãæãŸããã ïœâPAã®å€ãã®åçµä¹Ÿç¥å»è¬è£œå€ãåŸæ¥æè¡
ã§ãããšãã°EPââ113319ããã³EPââ
123304ã«é瀺ãããŠããããããã®è£œå€ã¯ãã®PH
ãã»ãŒäžæ§ã§ããïœâPAã®æ°Žæ§å¡©é¡æº¶æ¶²ãã補
é ããããã®ãããªæº¶æ¶²äžã«ãããïœâPAã®æº¶
解床ã¯ã€ãªã³æ§æ¿åºŠãå¢å ããªããšäœããšããæ¬
ç¹ãæãããåŸã€ãŠããã®ãããªåçµä¹Ÿç¥è£œå€ã
ãåŸãããéçµè žæäžçšæº¶æ¶²ã¯æãç¶æ³ã§ã¯æãŸ
ãããªã倧éã®æº¶æ¶²ãæ£è ã«æäžããå¿ èŠããã
ã»ã©äœãæ¿åºŠã§ïœâPAãå«æããŠãããããŸã
ã¯é«åŒµæ§ã§ãã€ãŠãæäžãããšèµ€è¡çã«å¯ŸããŠæ
害ã§ããããšããããã®ãã¥ããã§ããã ããã«ãïœâPAã®æ°Žæº¶æ¶²äžã«ããã溶解床ãã
溶液ã®PHãé žçŽ ç¯å²å ã«ãããšæ¹åã§ããããšã
åçµä¹Ÿç¥å»è¬è£œå€ãïœâPAã®é žæ§æº¶æ¶²ãã補é
ã§ããããšãããã³ãã®è£œå€ãæäžããå Žåã«æ
æã®ççåŠçåé¡ã瀺ããªãéçµè žæäžçšæº¶æ¶²ã
æäŸã§ããããšãèŠãåºããããåŸã€ãŠãæ¬çºæ
ã¯ïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ã補é ããæ¹æ³ã
æäŸãããã®æ¹æ³ã¯PHãïŒãïŒã§ããïœâPAã®
å·å氎溶液ã也ç¥ãããããšãããªãæ¹æ³ã§ã
ãã ïœâPAã®æ¹åããã溶解床ã®çµæãšããŠãïœ
âPAã溶液ããæ²æŸ±ããæåºãããã¥ããã®å®
質çãªå±éºãä»éããããšãªããé«æ¿åºŠã§ïœâ
PAãå«æããéçµè žæäžçšæº¶æ¶²ãæäŸã§ããå
çµä¹Ÿç¥å»è¬è£œå€ãæ¬çºæã«åŸã補é ã§ãããåŸã€
ãŠãæ¬çºæã«ããå¿ èŠãªæããã³å¿ èŠãªå Žåã«ã
補å€ãããšãã°äžæ§ãŸãã¯é žæ§PHã®æ°Žã䜿çšããŠ
ææã®æ¿åºŠã«æº¶è§£ã§ããå»åž«ãŸãã¯ç£å»åž«ã«åçµ
也ç¥è£œå€ãæäŸã§ãããããªãã¡ãæ¬çºæã¯ãã®
åãæ±ãã極ããŠæè»ã§ãã€ãŠãå»åž«ããã³ç£å»
åž«ã«ãã䜿çšã§ããå®å®ãªåçµä¹Ÿç¥å»è¬è£œå€ãæ
äŸãããšãšãã«ã移éããã³è²¯èµãããã«ç°¡äŸ¿ãª
æ段ãæäŸããã æ¬çºæã§äœ¿çšããïœâPAã¯åºä¹³åç©ã«å®è³ªç
ã«å¯Ÿå¿ãããã¥ããã®çç©æŽ»æ§ã¿ã³ãã¯è³ªãç¹ã«
ããïœâPAã§ããããšãã§ããã°ãªã³ã·ã«åã
ãŠãã圢ããã³ã°ãªã³ã·ã«åããŠããªã圢ã®ãã®
ãå å«ãããããã¯EPââ112122ã«èšèŒãã
ãŠãããããªïŒé圢ãŸãã¯ïŒé圢ïœâPAã§ãã
ããšãã§ããå åã«ã°ãªã³ã·ã«åããŠããããïœ
âPAã®å Žåã«ãçŽ70000ã®ããªã¢ã¯ãªã«ã¢ããã²
ã«ã«ããšã¥ãèŠæãäžã®ååéããã³7.5ã8.0ã®
çé»ç¹ãæããã奜ãŸããã¯ãïœâPAã¯çŽ
500000IUïŒmgã®æ¯æŽ»æ§ãæãããIU.ïŒmgïŒåœé
åäœïŒmgïŒåœéåäœã¯WHOããã·ãšãã« ã€ã³
ã¹ãããŠãŒã ããªã¢ ãã€ãªããžã«ã« ã¹ã¿ã³
ããŒã ã¢ã³ã ã³ã³ãããŒã«ïŒNational
Institute for Biological Standards and
ControlïŒãããŒãªã€ ãã«ããã ãã¹ããããã
ã³ãã³ïŒHolly HillãHampsteadãLondonïŒ
NW ïŒ ïŒ RBãè±åœã«ããèŠå®ãããŠãããš
ããã®æŽ»æ§åäœã§ãããã ïœâPAã®ã¢ããé žé åã¯å¥œãŸããã¯ç¬¬ïŒå³ã«
èšèŒã®é åã«å®è³ªçã«çžåœãããããªãã¡ããã®
é åã¯ç¬¬ïŒå³ã®é åãšåäžã§ãããããŸãã¯å¯Ÿç«
圢質æºã§ãããã¯ãã®ä»ã®äžçš®ãŸãã¯äºçš®ä»¥äžã®
ã¢ããé žã®æ¬ èœã眮ãæããæ¿å ¥ã転äœãŸãã¯ä»
å ãå«ã¿ãçæããé åã¯ç¬¬ïŒå³ã®é åãšå°ãªã
ãšã80ïŒ ã奜ãŸããã¯90ïŒ ã®çžåæ§ãæãããã®
ã¿ã³ãã¯ã®åäžã®çç©åŠçããã³å ç«åŠçæ§è³ªã
åºæ¬çã«ä¿æããŠãããç¹ã«ãïœâPAé åã¯ç¬¬
ïŒå³ã®é åãšåäžã§ãããããããã¯ã»ãªã³ïŒ®â
æ«ç«¯ãã245çªç®ã®äœçœ®ã«ã¡ããªãã³ã®ä»£ãã«ã
ãªã³ãæãã以å€ã¯åäžé åãæãããããã©ã¡
ãã®é åãå Žåã«ãããæåã®ïŒåã®ã¢ããé žã«
ãã¥ãããååšããŠããªããããŸãã¯å Žåã«ãã
GlyâAlaâArgã®è¿œå ã®ããªããããâæ«ç«¯
å è¡é åãæããã 第ïŒå³ã«ç€ºãããŠããã¢ããé žé åã¯35ã®ã·ã¹
ãã€ã³æ®åºãæããåŸã€ãŠ17ã®ãžã¹ã«ãã€ãæ©ã
圢æããèœåãæãããæ§é ãããã«è©³çŽ°ã«æ±ºå®
ãããŠãããã®ä»ã®ã¿ã³ãã¯ãšã®åææ§ã«ããšã¥
ãã90çªç®ã®äœçœ®ã®ã¢ããé žãšãããªã³ïŒ£âæ«ç«¯
ãšã®éã®é åã«ã€ããŠã®ä»®å®æ§é ã第ïŒå³ã«ç€ºã
ããŠããã第ïŒå³ã«ãããŠãïŒå°ã¯ïŒé圢ïœâ
PAãäžããïŒé圢ïœâPAã®éè£éšäœã瀺ãïŒã
ãã§ïŒ¡éã¯ïŒã€ã®ç°ç¶ïŒKringleïŒé åãå«ã¿ã
ãããŠïŒ¢éã¯ã»ãªã³ãããã¢ãŒãŒé åãå«æã
ãããã®ïŒ®âæ«ç«¯é åã®æ§é ã¯ç¢ºå®ããŠããªã
ããããã€ãã®ææ¡ãæ瀺ãããŠãããããã°ã¬
ã¹ ã€ã³ ãã€ããªããªã·ã¹ïŒProgress in
FibrinolysisïŒã1983幎ãïŒã269ã273é ïŒãã
ã³ããã¯ïŒããã«ïŒã¢ã«ãïŒãµã€ïŒïŒProc.Natl.
Acad.Sci.ïŒ1984幎ã81ã5355ã5359é åç §ããïœ
âPAã®æ§é ã®æãéèŠãªç¹åŸŽã¯ãã®ã¿ã³ãã¯ã
ãã€ããªã³ã«çµåãã圹ç®ãã¯ãããŠããïŒã€ã®
ç°ç¶éšåïŒ92çªç®ã®ã¢ããé žãš173çªç®ã®ã¢ãã
é žã®éããã³180çªç®ã®ã¢ããé žãš261çªç®ã®ã¢ã
ãé žãšã®éïŒããã³ïŒ¢éã®äž»èŠé åãå«ãããšã
ãã³ããã©ã¹ãããŒã²ã³ã®æŽ»æ§åã®åœ¹ç®ãã¯ãã
ã»ãªã³ãããã¢ãŒãŒé åã«ãããã»ãªã³ãããã¢
ãŒãŒé åã«ãããç¹å¥ã«éèŠãªã¢ããé žã¯è§Šåªç
äžãçµã¢ããé žãHisïŒAspïŒSerã§ãããïœâ
PAã«ãããŠã¯ããããã¯322çªç®ã371çªç®ãã
ã³463çªç®ã«äœçœ®ããŠããã264çªç®ããã³395çª
ç®ã®ã·ã¹ãã€ã³ã¢ããé žæ®åºããŸãéèŠã§ããã
ãããã¯ïœâPAã®ïŒã€ã®é圢ã®ïŒ¡éãšïŒ¢éãšã
äžç·ã«ä¿æããŠããã 第ïŒå³ããã³ç¬¬ïŒå³ã«ãããŠãã¢ããé žæ®åºã«
ã€ããŠäžèšã®ãšããã®æ £çšã®ïŒåèšå·ããã³ïŒå
èšå·ã䜿çšããïŒ Asp  ã¢ã¹ãã©ã®ã³é ž Ile  ã€ãœãã€ã·
ã³ Thr  ã¹ã¬ãªãã³ Leu  ãã€ã·ã³ Ser  ã»ãªã³ Tyr  ããã·ã³ Glu  ã°ã«ã¿ãã³é ž Phe  ããšãã«ã¢ã©
ãã³ Pro  ãããªã³ His  ãã¹ããžã³ Gly  ã°ãªã·ã³ Lys  ãªãžã³ Ala  ã¢ã©ãã³ Arg  ã¢ã«ã®ãã³ Cys  ã·ã¹ãã€ã³ Trp  ããªãããã¢ã³ Val  ããªã³ Gln  ã°ã«ã¿ãã³ Met ïŒ ã¡ããªãã³ Asn  ã¢ã¹ãã©ã®ã³ ïœâPAã¯åœæè¡ã§æ¢ç¥ã®ãŸãã¯é瀺ãããŠã
ã補é æ¹æ³ã®ãã¥ããã«ããåŸãããšãã§ããã
äžäŸãšããŠãïœâPAã¯ãã€ãªããã« ãš ãã€
ãªãã€ã·ã« ã¢ã¯ã¿ïŒBiochimica et
Biophysica ActaïŒã1979幎ã580ã140ã153ïŒ
EPââ41 766ãŸãã¯EPââ113 319ã«èšèŒ
ãããŠããçš®é¡ã®æ£åžžãŸãã¯è «çã»ã«ã©ã€ã³ãã
åŸãããšãã§ãããããããªãããïœâPAã¯ã
ããšãã°EPââ93 619ïŒEPââ117 059ãŸ
ãã¯EPââ117 060ã«èšèŒãããŠãããããª
DNAçµæãææ³ãçšããŠèªå°ãããå¹é€ãã圢
質転æãŸãã¯ãã©ã³ã¹ããšã¯ã·ãšã³ãããã»ã«ã©
ã€ã³ããåŸããšå¥œãŸãããïœâPAã®è£œé ã«ãã€
ã€ããŒãºãã ã¹ã¿ãŒåµå·£ïŒCHOïŒçŽ°èã䜿çšãã
ã¢ã¬ããŠã©ãŒ ã¢ã³ã ã»ã«ã©ãŒãã€ãªããžã€
ïŒMolecular and Cellular BiologyïŒã1985幎ïŒ
(7)ã1750ã1759é ã«èšèŒã®æ¹æ³ã§èªå°ãããšç¹ã«
奜ãŸããããã®æ¹æ³ã§ãã¯ããŒã³åãããéºäŒå
ããžãããããªã¬ãŒãã¬ãã¯ã¿ãŒãŒïŒdhfrïŒã
dhfrâCHO现èã«ã³ãŒãããéºäŒåã«ããã³ã
ã©ã³ã¹ããšã¯ã·ãšã³ãããã圢質転æäœãçºçŸã
ãdhfrã¯ãã¯ã¬ãªã·ãäžå«å¹å°ã§éžæãããå¢å
ããæ¿åºŠã®ã¡ããã¬ãã»ãŒãã«ãããããããã
ããŠãdhfrããã³ïœâPAéºäŒåã¯å ±ã«å¢å¹ ãã
ãŠãé«ã¬ãã«ã®ïœâPAãçºçŸããããšãã§ãã
å®å®ãªã»ã«ã©ã€ã³ãå°ãã ïœâPAã¯å¥œãŸããã¯ãäžèšã®æç®ã«èšèŒãã
ãŠãããããªåœæè¡ã§æ¢ç¥ã®ãŸãã¯é瀺ãããŠã
ãæ¹æ³ã®ãã¥ãããçšããŠç²Ÿè£œããïŒãã€ãªã±ã
ã« ãš ãã€ãªãã€ãžã« ã¢ã¯ã¿
ïŒBiochimicaet Biophysica ActaïŒã1979幎ã
580ã140ã153é ïŒãžã€ãŒãã« ãªã ãã€ãªã
ãžã«ã« ã±ãã¹ããªã€ïŒJ.Biol.Chem.ïŒã1979幎ã
254(6)ã1998ã2003é ïŒåã1981幎ã256ïŒ13ïŒã
7035ã7041é ïŒãšãŒããã ãžã€ãŒãã« ãªã
ãã€ãªã±ãã¹ããªã€ïŒEur.J.Biochem.ïŒã1983
幎ã132ã681ã686é ïŒEPââ41 766ïŒEPâ
â113 319ïŒãŸãã¯GBââïŒ 122 219ã æ¬çºæã®æ¹æ³ã§äœ¿çšããïœâPAã®æ°Žæº¶æ¶²äžã«
ããã溶解床ã«ã¯ãã¥ããã®äžéãååšãããã
ã«ã¯ã¿ããªãã150000000IU.ïŒmlïŒåœéåäœïŒ
mlïŒãã倧ãããããªæ¥µããŠé«ãæ¿åºŠã§ãã溶液
ã¯ãã¥ãã®ææã®ïœâPAæ²æ®¿ããšããªãããšãª
ãåã«ç²æ§ã«ãªãã ãã§ãããåŸã€ãŠã氎溶液äž
ã«ãããïœâPAã®æ¿åºŠã¯åºãéçå ãããšãã°
50000ã50000000IUïŒmlã§å€ããããšãã§ããã
æ¬çºæããæé«ã®å©çã確ä¿ããããã«ã¯ãïœâ
PAã®æ¿åºŠã¯100000IUïŒmlãã倧ãããã«ç¹ã«
500000IUïŒmlãã倧ãããã«ç¹ã«1000000IUïŒml
ãã倧ã§ãããïœâPAã®æ¿åºŠãçŽ5000000IUïŒ
mlã§ãããšæé«ã«å¥œãŸããã 氎溶液ã®PHã®äžéã¯å¥œãŸããã¯4.5ã§ãããå®
éã«ããã®PHã¯å¥œãŸããã¯2.5ã4.0ã®ç¯å²ããã
ã«å¥œãŸããã¯2.8ã3.5ã®ç¯å²ãããã«ç¹ã«å¥œãŸã
ãã¯çŽ3.0ã§ããã氎溶液ã®ææã®PHã¯ççåŠç
ã«èš±å®¹ããããç¡æ©ãŸãã¯ææ©é žãçšããŠåŸããš
簡䟿ã§ããããã®ãããªé žã®äŸã«ã¯å¡©é žãç¡«é žã
ãã³ç¡é žã䞊ã³ã«ã¯ãšã³é žãé ç³é žããã³ãã³ãŒ
ã³ã¹ã«ãã³é žãå å«ãããããããã®äŸã®äžã§å¡©
é žã奜é©ã§ããã æãçš®ã®ççåŠçã«èš±å®¹ããããå ±æº¶å€ãæ°Žã«
å ããŠå Žåã«ããååšãããããšãã§ããããæ°Ž
溶液çšã®åªè³ªã¯å šäœçã«ãããã¯å®è³ªçã«æ°Žæ§ã§
ãããšå¥œãŸããã åçµä¹Ÿç¥å»è¬è£œå€ããåŸãããéçµè žæäžçšæº¶
液ã¯æ£è ã®è¡æž ãšé匵ãäœåŒµãŸãã¯ç匵ã§ããã
ãšãã§ãããããããªãããæãŸãããªãå¯äœçš
ãåé¿ããããã«ãéçµè žæäžçšæº¶æ¶²ã¯ç匵ã§ã
ããšå¥œãŸãããäœåºŠã®å€åã¯ççåŠçã«ããŸãé¢
ä¿ã¯ãªããå®è³ªçã«ç匵æ§ã®éçµè žæäžçšæº¶æ¶²ã¯
溶液ã®åŒµåºŠãèŠæ±ãããã¬ãã«ã«äžæãããããš
ãã§ããççåŠçã«èš±å®¹ããããå©å€ãå«ãŸãã
ããšã«ããåŸãããšãã§ããããã®ãããªå©å€ã¯
åçµä¹Ÿç¥å»è¬è£œå€äžã«ãã§ã«ååšããããã«åçµ
也ç¥ããã氎溶液ã®äžã«å«ãŸããããšãã§ããã
ããã¯ææã®éçµè žæäžçšæº¶æ¶²ãåŸãããã«ãã®
ãããªè£œå€ã溶解ããããã«çšããããäžæ§ãŸã
ã¯é žæ§PHã®æ°Žã®äžã«å«æãããããšãã§ãããã
ã®ãããªå©å€ã®äŸã¯åœæè¡ã§ããç¥ãããŠããã
ããã¹ãããŒã¹ïŒç¡æ°Žç©åœ¢ãŸãã¯äžæ°Žåç©åœ¢ïŒã
ãã³å¡©åãããªãŠã ããã³ãŸããã®æ··åç©ãå å«
ããã氎溶液ãŸãã¯æº¶è§£çšæ°Žäžã®ãã®ãããªå©å€
ã®æ¿åºŠã¯äœ¿çšããç©è³ªã«ããå€ããããšã¯å¿è«ã®
ããšã§ãããå¡©åãããªãŠã ã®å Žåã«ããã®æ¿åºŠ
ã¯å¥œãŸããã¯ïŒã10mgïŒmlãããã«å¥œãŸããã¯çŽ
8.5mgïŒmlã§ããããã®æ¿åºŠã¯ãã°ãã°ççé£å¡©
液ãŸãã¯ççé£å¡©æ°Žãšç§°ãããæ¿åºŠã§ãããç¡æ°Ž
ããã¹ãããŒã¹ã®å Žåã«ããã®æ¿åºŠã¯å¥œãŸããã¯
30ã70mgïŒmlãããã«å¥œãŸããã¯çŽ50mgïŒmlã§ã
ãã 氎溶液ã¯å Žåã«ãããã®çš®ã®åçµä¹Ÿç¥å»è¬è£œå€
ãéåžžå«æããæ·»å å€ãå«æã§ããããã®ãããª
äŸãšããŠã¯ããè¡æž ã¢ã«ããã³ãçµåå€ãããã
ããŒã«ãä¹³ç³ããã³ã°ã«ã³ãŒã¹ã®ãããªå å¡«å€ã
å å«ãããããã«ãïœâPAã¯ã¬ã©ã¹ããã³ãã©
ã¹ããã¯è¡šé¢ã«åžçããåŸåããããåŸã€ãŠãã®
ãããªåžçãé²æ¢ãããããŸãã¯æäœã«ãããã
ã«ã氎溶液äžã«è¡šé¢æŽ»æ§å€ãå«æãããããšãæ
ãŸããããšãããããã®ãããªè¡šé¢æŽ»æ§å€ã®äŸã«
ã¯ããã€ãŒã³80ãïŒTween80ïŒã®åååã§åžè²©ã
ããŠãããããªç¡æ°Žãœã«ãããŒã«ã®èèªé žéšåãš
ã¹ãã«ã®ããªãªãã·ãšãã¬ã³èªå°äœãå«ãŸããã æ¬çºæã®é©ãã¹ãå©ç¹ã®äžã€ãšããŠã¯ãïœâ
PAã®å®è³ªçã«å¢å€§ãã溶解床ã¯å¥ã«ããŠãåçµ
也ç¥å»è¬è£œå€ã®åæ§æã«ããåŸãããé žæ§éçµè ž
æäžçšæº¶æ¶²ã®äœ¿çšãæ£è ã«æäžããæã«ãã¥ãã
ææã®æ害ãªççåŠçäœçšã瀺ããªãããšã«ã
ããè¡æµã¯äžè¬ã«ã溶液ã®PHãæ¥è§Šããã»ãšãã©
ããã«äžæ§ã«äžæãããããã«èŠããïœâPAã¯
è¿ éã«è¡æµå ã«ååžããããããããªããããã®
æ¹æ³ã¯ãã¥ãã®æ¹æ³ã§ãå®è³ªçã«åŠšå®³ãããªãã
ãšããã³ãã®éçµè žæäžçšæº¶æ¶²ããã³åçµä¹Ÿç¥ã
ãã氎溶液ããã³ãŸãåæ§æçšã®æ°Žã¯åŒ·åãªç·©è¡
å€ãå«æããªãããšã奜ãŸããããããããã®æ¹
æ³ãææã«é»å®³ããªã匱ãç·©è¡å€ã¯å«ãŸããŠãã
ããé žæ§PHã§ïœâPAããèªäœãããèªäœã§åŒ±ã
ç·©è¡å€ãšããŠäœçšããããšã確ãã§ãããããã«
ãŸããããè¡æž ã¢ã«ããã³ã¯åŒ±ãç·©è¡å€ãšããŠäœ
çšã§ããã ïœâPAãïŒãïŒã®PHã®æ°Žæº¶æ¶²äžã§å®è³ªçã«å¢
倧ãã溶解床ãæããããšããããã®åçµä¹Ÿç¥è£œ
å€ã®åæ§æããåŸãããéçµè žæäžçšæº¶æ¶²ã«ã¯ïœ
âPAã®æº¶è§£åºŠãå¢åŒ·ããããã®ãªãžã³ãŸãã¯ãª
ã«ããã³ãããã¯ãã®æ··åç©ã®ãããªãã¥ããè¿œ
å ã®å©å€ãå«æãããå¿ èŠã¯ãªãã ïœâPAã®æ°Žæº¶æ¶²ã¯ç²Ÿè£œããïœâPAã®æº¶æ¶²ã
åŸã次ãã§ïŒãïŒã®PHãæããæ°Žæ§åªè³ªçšã¡ãžãŠ
ã ãšäº€æããããšã«ããããããã¯ç²Ÿè£œããïœâ
PAãïŒãïŒã®PHãæããæ°Žæ§ã¡ãžãŠã äžã«æº¶è§£
ããããšã«ãã調補ã§ããã ïœâPAã®ç²Ÿè£œã¯ã¯ãããã°ã©ãã€ã«ã©ã ãã
匷åãªç·©è¡å€ãå«æãã溶液ãšããŠã¿ã³ãã¯ã溶
é¢ããå·¥çšãæçµå·¥çšãšããŠå«ãããšãã§ããã
åèšããããã«ãéçµè žæäžçšæº¶æ¶²ããã³åŸã€ãŠ
åçµä¹Ÿç¥å»è¬è£œå€ããã³æ°Žæº¶æ¶²ã¯åŒ·åãªç·©è¡æå€
ãå«æããŠããªããåŸã€ãŠããã®é€å»ãè¡ãªãç°¡
䟿ãªæ段ãšããŠã¡ãžãŠã ã®äº€æã«éæã䜿çšãã¹
ãã§ãããéæã¯ç²Ÿè£œæº¶æ¶²ãïŒãïŒã®PHãæãã
æ°Žæ§ã¡ãžãŠã ã«å¯ŸããŠéæãããéæ管ãŸãã¯äºº
å·¥è èãçšããŠå®æœã§ãããç¹ã«ç²Ÿè£œæº¶æ¶²äžã®ïœ
âPAã®æ¿åºŠãé«ãå Žåã«ã¯ãå ããã®æº¶æ¶²ã®PH
ãïŒãïŒã«èª¿è£œããããšãæãŸããããšãããã
匷åãªç·©è¡å€ãé€å»ãããšãšãã«ã¡ãžãŠã ã亀æ
ããããã®ããäžã€ã®æ段ã¯ç²Ÿè£œæº¶æ¶²ãã²ã«æ¿Ÿé
ãã次ãã§ïŒãïŒã®PHãæããæ°Žæ§ã¡ãžãŠã ã§ã«
ã©ã ãå±éããæ¹æ³ã§ããã æ²æ®¿ããåºäœã®åœ¢ã®ïœâPAã¯å¥œãŸããã¯ç²Ÿè£œ
溶液ãããã®PHãçŽ5.5ã«èª¿è£œãã溶液ããã®å
çµç¹ã®ããäžã®æž©åºŠãŸã§å·åŽãã次ãã§ããšãã°
é å¿åé¢ã«ããã¿ã³ãã¯ãåãåºãããšã«ããåŸ
ãããšãã§ãããæ²æ®¿ããåºäœã¯æ¬¡ãã§ïŒãïŒã®
PHãæããæ°Žæ§åªè³ªäžã«åžžæ³ã«ãã溶解ã§ããã çæãã氎溶液ã¯éœåè¯ããããšãã°æ¿Ÿé殺è
ã«ãã殺èããããã³æ¬¡ãã§ã¢ã³ãã«ãŸãã¯ãã€
ã¢ã«ã®ãããªç¡èãã©ã¹ããã¯ãŸãã¯ã¬ã©ã¹å®¹åš
ã«ãããšãã°0.5ã20mlã®å®¹éã§åé ããã ïœâPAã®æ°Žæº¶æ¶²ã¯ã奜ãŸããã¯â10ãâ40â
ã®æž©åºŠã§å·åãããå·åãã氎溶液ã¯æ¬¡ãã§ã奜
ãŸããã¯ãã®æž©åºŠã«ç空也ç¥ãéå§ãããŸã§ä¿æ
ããã å·åãã氎溶液ã®ç空也ç¥ã¯é©å®ã«å®æœã§ãã
ããšãã°0.01ã0.1ããŒã«ã§å®è³ªçã«å šãŠã®å·å
液ã®é€å»ãè¡ãªããããŸã§å åãªæéãéšåçç
空ãŸãã¯å®å šç空äžã«ä¹Ÿç¥ãããããšãå å«ã
ãã ç空也ç¥ãè¡ãªã枩床ã¯éåžžã氎溶液ãå®è³ªç
ã«ãŸãã¯å®å šã«åçµãã圢ã§ç¶æãããããã«ã
åŠçã®éå§æç¹ã§â30ãâ40âã§ãããåŠçœ®ãé²
è¡ããæ°Žãé€å»ãããã«ã€ããŠã枩床ã¯å®€æž©ã«é
ãããŸã§æ¬¡ç¬¬ã«äžæããããšããããæåŸã®çè·¡
éã®æ°Žãã§ããã ãé€å»ããããã«ãåŠçã®çµäº
æç¹ã«ãããŠå®€æž©ãŸãã¯ãã®ããäžæž©åºŠã§çŽ0.01
ããŒã«ã®å®è³ªçç空äžã«ç空也ç¥ãè¡ãªããšå¥œãŸ
ãããçæããåçµä¹Ÿç¥å»è¬è£œå€ã®æ°Žå«æéã¯å¥œ
ãŸããã¯2.5ïŒ ä»¥äžã§ãããç空也ç¥ãå®äºãã
ãªãã°ãåçµä¹Ÿç¥ãããå»è¬è£œå€ãå«æããç¡è
ã®ãã©ã¹ããã¯ãŸãã¯ã¬ã©ã¹å®¹åšãéœåè¯ãå¯å°
ããã å·åãã氎溶液ã®ç空也ç¥äžã«ãæ°Žãé€å»ã
ããïœâPAãççåŠçã«èš±å®¹ããããå¡©ã®åœ¢ã§
æ®ããåŸã€ãŠãæ¬çºæã¯ãŸãïœâPAã®ççåŠç
ã«èš±å®¹ããããå¡©ãç¹ã«å¡©é žå¡©ã®ãããªççåŠç
ã«èš±å®¹ããããé žä»å å¡©ãæäŸããã æ¬çºæã䜿çšããããšã«ããé«æ¿åºŠã§ïœâPA
ãå«æããéçµè žæäžçšæº¶æ¶²ãæäŸã§ããåçµä¹Ÿ
ç¥å»è¬è£œå€ãæåã«åŸãããšãã§ãããåŸã€ãŠã
æ¬çºæã¯ãŸãæ°Žãå ãããšïœâPAã100000IUïŒ
mlãã倧ã®ãããã«ç¹ã«500000IUïŒmlãã倧ã®ã
æãç¹å¥ã«1000000IUïŒmlãã倧ã®æ¿åºŠã§æäŸã
ãããšãã§ããïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ãæ
äŸããã æäžçšã®ïœâPAã®éçµè žæäžæº¶æ¶²ã調補ãã
ã«ã¯ãæ¬çºæã®æ¹æ³ã«ããåŸãããåçµä¹Ÿç¥å»è¬
補å€ãäžæ§ãŸãã¯é žæ§PHã®æ°Žã§åæ§æãããåçµ
也ç¥å»è¬è£œå€ãåŸããã氎溶液ãå®è³ªçã«ç匵ã§
ããå Žåã«ãåæ§æçšã®æ°Žã¯ãŸãå®è³ªçã«åŒµçã§
ãããšå¥œãŸããã è¡å¡ã®ãã€ããªã³ç¶²ç¶æ§é ã溶解ããéã®ïœâ
PAã®çç©åŠç掻æ§ã¯è¡æ æ§é害ã®åŠçã«ããã
ãã®äœ¿çšãå°ããŠããã㶠ã©ã³ã»ããïŒThe
LancetïŒã1981幎11æïŒæ¥ã1018ã1020é ïŒ1985
幎ïŒæ13æ¥ã842ã847é ïŒã¶ ããŠãŒ ã€ã³ã°ã©
ã³ã ãžã€ãŒãã« ãªã ã¡ãã€ã·ã³ïŒThe
New England Journal of MedicineïŒã1984幎ã
310(10)ã609ã613é ïŒåã1985幎ã312ïŒ14ïŒã932
ã936é ããåŸã€ãŠãæ¬çºæã¯åºä¹³åç©ã«ãããè¡
æ æ§é害ã®åŠçœ®æ¹æ³ãæäŸãããã®æ¹æ³ã¯åèšå®
矩ã®ãšããã®åçµä¹Ÿç¥å»è¬è£œå€ããåŸãããïœâ
PAã®éçµè žæäžçšæº¶æ¶²ãåºä¹³åç©ã«æäžããã
ãšãå«ãã§ãããå¥æ§ã«ã¯ããããŸãã¯åç©ã«äœ¿
çšãããç¹ã«è¡æ æ§é害ã®åŠçœ®ã«äœ¿çšããããã®
ïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ãæäŸããã è¡æ æ§é害ã®ç¹å®ã®äŸã¯åœæ¥è ã«ç¥ãããŠãã
ããå¿çæ¢å¡ãæ·±åèè¡æ çãèºå¡æ çããã³å
äžãå å«ããã ïœâPAã®äž»èŠæäžçµè·¯ã¯è¡ç®¡å ãç¹ã«éèå
æ³šå ¥ã«ããããèãããããã®ä»ã®æäžçµè·¯ãã
ãšãã°çèå æäžã䜿çšã§ãããè¡ç®¡å æ³šå ¥ã¯é
åžžãæ³šå ¥çšè¢ãŸãã¯ãã³å ã«ãããã¯é»æ°çã«æ
äœãããæ³šå ¥ã·ãªã³ãå ã«å«æãããŠããéçµè ž
æäžçšæº¶æ¶²ãçšããŠè¡ãªãããã®æº¶æ¶²ã¯æ³šå ¥è¢ãŸ
ãã¯ãã³ããæ£è ã«éåäŸçµŠã«ããããŸãã¯æ³šå ¥
ãã³ãã䜿çšããããšã«ããäžããããšãã§ã
ããééäŸçµŠæ³šå ¥ã·ã¹ãã ã䜿çšãããšãéçµè ž
æäžçšæº¶æ¶²ã®æäžé床ãç·äœçã«å åã«å¶åŸ¡ããŠ
äŸçµŠã§ããªããåŸã€ãŠãæ³šå ¥ãã³ãã®äœ¿çšãæ¯èŒ
çé«æ¿åºŠã®ïœâPAãå«æãã溶液ã®å Žåã«ç¹ã«
奜é©ã§ãããããããªãããããã«å¥œãŸããã¯ã
æäžé床ãç·äœçã«ãã倧ããå¶åŸ¡ã§ããé»æ°ç
ã«æäœããæ³šå ¥ã·ãªã³ãžã䜿çšããã è¡æ æ§é害ãæã€åºä¹³åç©ã®åŠçœ®ã«æå¹ãªïœâ
PAã®éã¯å€ãã®å åãããšãã°åºä¹³åç©ã®å¹Žä»€
ããã³äœéãåŠçœ®ãå¿ èŠãšããæ£ç¢ºãªçç¶ããã³
ãã®é節床ãæäžçµè·¯ãå«ãå åã«äŸåããŠå€ã
ãããšã¯å¿è«ã§ããã究極çã«ã¯äž»æ²»å»ãŸãã¯äž»
æ²»ç£å»ã®è£éã§ãããããããªãããããšãã°å
ç¶åèè¡æ ã溶解ãããæå¹éã¯äžè¬ã«150000ã
450000IUïŒæ£è ã®äœéKgïŒæã®ç¯å²ã§ãããšå¥œ
ãŸãããåŸã€ãŠãäœé70Kgã®æ人ã®å Žåã«ãïŒæ
éåœãã®æå¹éã¯äžè¬ã«10000000ã30000000IUã
ç¹ã«çŽ20000000IUã§ããããã®éã¯ååéãçš
ããŠãŸãã¯çšããããšãªãæäžã§ãããããã«ã
ãã®æäžéã¯ããã€ãã®è¡æ çç¶ãããšãã°æ·±å
èè¡æ çããã³æ¥æ§åäžã®ãããªçç¶ã«å¯ŸããŠ
ã¯ããŸãã¯ãã§ã«åæœ æµãããŠããå ç¶åèã®é
æŸæ§ãåçŽã«ç¶æããããã®å Žåã«ã¯ããã«å°é
ã«ãããšå¥œãŸããããããã®å Žåã«ãæå¹éã¯äž
è¬ã«7000ã36000IUïŒæ£è ã®äœéKgïŒæã§ããã 次äŸã¯æ¬çºæãäŸç€ºããããã«ç€ºããã®ã§ãã€
ãŠãæ¬çºæããã¥ãã®ç¹ã§ãå¶éããããšããã
ã®ã§ã¯ãªãã äŸ ïŒ ã¢ã¬ããŠã©ãŒ ã¢ã³ã ã»ã«ã©ãŒ ãã€ãªããž
ã€ïŒMolecular and Cellular BiologyïŒã1985
幎ãïŒ(7)ã1750ã1759é ã®æ¹æ³ã䜿çšããŠèªå°ã
ããå¹é€ãã圢æ転æãããCHOã»ã«ã©ã€ã³ã
ãåŸãããïœâPAã®æž æµã«ããåç©«ç©ãã¯ãã
ãã°ã©ãã€ã«ãã粟補ããïœâPAã0.17Mã¯ãš
ã³é žãããªãŠã ããã³0.01ïŒ ïŒééïŒå®¹éïŒãã€
ãŒã³ïŒïŒãå«æããPH5.5ã®æ°Žæº¶æ¶²ãšããŠæ¡åã
ãã溶液ã®PHãå¡©é žã§3.0ã«èª¿æŽããçæãã溶
液ãâ10ã«ãŒããªããžïŒCartridgeïŒãã¢ãã³ã³
瀟ïŒAmicon Ltd.ïŒã¢ãã㌠ãã«ãã¹ããŒã³
ããŠã¹ãã°ãã»ã¹ã¿ãŒã·ã€ãŒïŒUpper Hillã
StonehouseãGloucestershireïŒãè±åœããçšããŠ
é å¿åé¢ã«ããæ¿çž®ãããæ¿çž®ãã氎溶液ãã²ã«
æ¿Ÿéã«ã©ã ãã»ãã¢ããã¯ã¹ïŒSephadexïŒïŒ§â
150ïŒãã¢ãŒãã·ã¢ ãã€ãªãã¯ãããžã€ç€Ÿ
ïŒPharmacia BiotechnologyïŒãã¢ãããµã©ãã¹
ãšãŒãã³ïŒUppsalaãSwedenïŒãã«é©çšãã0.01
ïŒ ïŒééïŒå®¹éïŒãã€ãŒã³ïŒïŒãå«æãã0.85ïŒ
å¡©é¡æº¶æ¶²ã§3.0ã®PHã«ãããŠæº¶åºããããšã«ãã
ããã«ç²Ÿè£œããããã®ããã«ããŠåŸãããé«åºŠã«
粟補ãããïœâPAã®æ°Žæº¶æ¶²ã䜿ãæšãŠäººå·¥è è
ãçšããŠããäžåºŠæ¿çž®ãããïœâPAã¯PHãæ°Žé ž
åãããªãŠã ã§5.5ã«å¢å€§ãã次ãã§æžæ¿æ¶²ãïŒ
âã§ïŒæéä¿æããããšã«ãã溶液ããæ²æ®¿ãã
ãããã®æº¶æ¶²ãïŒâã§30åéã4000Ãïœã§é å¿å
é¢ããæ²æ®¿äžã«å šéšã§1680Ã106åäœã®ïœâPAã
æ¡åããããã®ïœâPAãã¬ãããã0.01ïŒ ïŒé
éïŒå®¹éïŒã®ãã€ãŒã³ïŒïŒãå«æããå¡©åãããª
ãŠã ã®æ°Žæº¶æ¶²ã0.85ïŒ ïŒééïŒå®¹éïŒã2300ml
ïŒ7500000IUïŒmlã10000000IUïŒmlã®æ¿åºŠããã
ã«å¿ èŠãªéïŒäžã«å溶解ããå¡©é žã§PH3.0ã«èª¿æŽ
ããããã®å溶解ããïœâPAãã¬ããã«ã€ããŠ
ïœâPA掻æ§ãç¹°è¿ã枬å®ãã8.09Ã106IUïŒmlã®
ïœâPA掻æ§ãåŸãããã®ïœâPAã®æº¶æ¶²ãã0.01
ïŒ ïŒééïŒå®¹éïŒã®ãã€ãŒã³ïŒïŒãå«æããå¡©å
ãããªãŠã ã®æ°Žæº¶æ¶²ã0.85ïŒ ïŒééïŒå®¹éïŒã490
mlã§ããã«åžéããå¡©é žã§PH3.0ã«èª¿æŽãã次ã
ã§åäžé žæ§å¡©é¡æº¶æ¶²äžã®10ïŒ ïŒééïŒå®¹éïŒãã³
ãããŒã«æº¶æ¶²930mlã§åžéãããããã«ãã€ãŠã
ïœâPA5000000IUïŒmlããã³ãã³ãããŒã«25
mgïŒmlãå«æãã溶液3720mlãåŸããçæãã溶
液ããã€ã«ã¿ãŒæ®ºèãã次ãã§ã¬ã©ã¹ãã€ã¢ã«äž
ã«ïŒmlã®å®¹éã§åé ãããã€ã¢ã«ãâ35âã§å·å
ããã0.05ããŒã«ã§æžå§ãé©çšãããçŽ24æéåŸ
ã«ã枩床ãåŸã ã«ïŒâã«äžæããããã®æž©åºŠã§16
æéä¿è·ããã次ãã§ãå床25âã«äžæãããæž
å§ã0.02ããŒã«ã«ããã«24æéå¢å€§ãããã®åŸã
ã€ã¢ã«ã也ç¥çªçŽ ã®600ããŒã«ã®éšåæžå§äžã«å¯
å°ããã äŸ ïŒ äŸïŒã®ïœâPAã®åçµä¹Ÿç¥è£œå€ããåŸãããé
çµå£æäžçšæº¶æ¶²ã®è¡æ 溶解å¹æãé éèè¡æ ã®ã€
ã³ããã¢ãã«ã§è©äŸ¡ããã (a) æ¹æ³ å®éšæ¹æ³ã¯ã³ã¬ã³ïŒCollenïŒä»ã«ããæåã«
èšèŒãããæ¹æ³ããžãšã€ïŒã¯ãªã³ïŒã€ã³ãã¹
ãïŒïŒJ.Clin.Invest.ïŒã1983幎ã71ã368ã376
é ãã«åºæ¬çã«åŸãã äŸïŒã®åçµä¹Ÿç¥è£œå€ãã0.01ïŒ ãã€ãŒã³ïŒïŒ
ãå«æããPH3.0ã«èª¿æŽããç¡èã®ç匵塩é¡æº¶
液ã«è¿ éã«ãå®å šã«æº¶è§£ããããã®åæ§æãã
ããïœâPAã®æ¿åºŠã¯50000IUïŒmlã§ãããã
ãããŠã500000IUïŒKgã®ïœâPAãïŒæéæ³šå ¥
ããããã®éçµå£æäžçšæº¶æ¶²ãåŸããããæ³šå ¥
ã¯å³å€§è ¿éšéèã§ã«ããŠãŒã¬ãçšããŠè¡ãªãã
ïŒå¹ã®ããŠãŒãžãŒã©ã³ãçœãŠãµã®ããã®å®éšã«
䜿çšãããæ³šå ¥åŸã«ãè¡æ 溶解ã®çšåºŠãè©äŸ¡ã
ãã (b) çµæ äŸïŒã®åçµä¹Ÿç¥è£œå€ããåŸãããéçµå£æäž
çšæº¶æ¶²ã®è¡æ 溶解å¹æã¯è¡æ æº¶è§£ïŒ ã§è¡šãããŠ
28.9±4.1ã§ãããããã«ããã®æº¶æ¶²ã«ããæ
害ãªåå¿ã¯èŠãããªãã
第ïŒå³ã¯ïœâPAã®ä»£è¡šçã¢ããé
žé
åã瀺ã
ãã®ã§ããããããŠç¬¬ïŒå³ã¯ïœâPAã®90çªç®ã®
äœçœ®ã®ã¢ããé žãšãããªã³ïŒ£æ«ç«¯ãšã®éã®ã¢ãã
é žé åã®ä»®å®æ§é ã瀺ããã®ã§ããã
ãã®ã§ããããããŠç¬¬ïŒå³ã¯ïœâPAã®90çªç®ã®
äœçœ®ã®ã¢ããé žãšãããªã³ïŒ£æ«ç«¯ãšã®éã®ã¢ãã
é žé åã®ä»®å®æ§é ã瀺ããã®ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ PHãïŒãïŒã§ããçµç¹ãã©ã¹ãããŒã²ã³æŽ»æ§
åå åïŒïœâPAïŒã®å·å氎溶液ãæžå§ä¹Ÿç¥ãã
ãŠåŸãããïœâPAã®åçµä¹Ÿç¥å»è¬è£œå€ã ïŒ ïœâPAãäžé圢ãŸãã¯äºé圢ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®è£œå€ã ïŒ ïœâPAã第ïŒå³ã«èšèŒãããŠããã¢ããé ž
é åãæãããããŸãã¯ã»ãªã³ïŒ®âæ«ç«¯ãã245
çªç®ã®ã¢ããé žãã¡ããªãã³ã®ä»£ãã«ããªã³ã§ã
ã以å€ã¯ç¬¬ïŒå³ãšåäžã¢ããé žé åãæããå Žå
ã«ããæåã®ïŒã€ã®ã¢ããé žã®ãããããååšã
ãŠããªããããŸãã¯å Žåã«ããGlyâAlaâArg
ã®è¿œå ã®ããªããããâæ«ç«¯å è¡é åãæãã
ãã®ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãŸãã¯ç¬¬ïŒé ã®
ããããäžã€ã«èšèŒã®è£œå€ã ïŒ ïœâPAãDNAçµæãæè¡ãçšããŠèªå°ãã
ãå¹é€ãã圢質転æãŸãã¯ãã©ã³ã¹ããšã¯ã·ãšã³
ãããã»ã«ã©ã€ã³ããåŸãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã第ïŒé ã®ããããäžé ã«èšèŒã®è£œå€ã ïŒ æ°Žæº¶æ¶²äžã®ïœâPAã®æ¿åºŠã100000IUïŒmlã
ã倧ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒé ã®ãã
ããäžé ã«èšèŒã®è£œå€ã ïŒ ïœâPAã®æ¿åºŠã500000IUïŒmlãã倧ã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®è£œå€ã ïŒ ïœâPAã®æ¿åºŠã1000000IUïŒmlãã倧ã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®è£œå€ã ïŒ ïœâPAã®æ¿åºŠã5000000IUïŒmlã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®è£œå€ã ïŒ æ°Žæº¶æ¶²ã®PHãïŒã4.5ã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã第ïŒé ã®ããããäžé ã«èšèŒã®è£œå€ã ïŒïŒ PHã2.5ã4.0ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®è£œå€ã ïŒïŒ PHã2.8ã3.5ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é ã«èšèŒã®è£œå€ã ïŒïŒ PHãçŽ3.0ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
ã«èšèŒã®è£œå€ã ïŒïŒ 氎溶液çšã®ã¡ãžãŠã ãå šäœçã«ãŸãã¯å®è³ª
çã«æ°Žæ§ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé
ã«èšèŒã®è£œå€ã ïŒïŒ 氎溶液çšã®ã¡ãžãŠã ã溶液ãããè¡æž ãšå®
質çã«ç匵ã«ããççåŠçã«èš±å®¹ããããå©å€ã
å«æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ãã
ããäžé ã«èšèŒã®è£œå€ã ïŒïŒ ççåŠçã«èš±å®¹ããããå©å€ãå¡©åãããª
ãŠã ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé ã«èšèŒã®è£œ
å€ã ïŒïŒ ççåŠçã«èš±å®¹ããããå©å€ãããã¹ãã
ãŒã¹ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé ã«èšèŒã®è£œ
å€ã ïŒïŒ 氎溶液ãè¡šé¢æŽ»æ§å€ãå«æããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããäžé ã«èšèŒã®è£œ
å€ã ïŒïŒ 氎溶液ãå®è³ªçã«ç·©è¡ãããŠããªãç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã第ïŒïŒé ã®ããããäžã€ã«èšèŒ
ã®è£œå€ã ïŒïŒ 氎溶液ããªãžã³ãŸãã¯ãªã«ããã³ãããã¯
ãã®å¡©ãå®è³ªçã«å«æããŠããªãç¹èš±è«æ±ã®ç¯å²
第ïŒé ã第ïŒïŒé ã®ããããäžé ã«èšèŒã®è£œå€ã ïŒïŒ 氎溶液ã殺èããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã
第ïŒïŒé ã®ããããäžé ã«èšèŒã®è£œå€ã ïŒïŒ ãããŸãã¯åç©å»è¬ãšããŠãç¹ã«è¡æ çé
害ã®åŠçœ®ã«äœ¿çšããããã®ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®è£œå€ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858513358A GB8513358D0 (en) | 1985-05-28 | 1985-05-28 | Formulation |
| GB8513358 | 1985-05-28 | ||
| GB8521705 | 1985-08-31 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5230427A Division JPH0759517B2 (ja) | 1985-05-28 | 1993-09-16 | çµç¹ãã©ã¹ãããŒã²ã³æŽ»æ§åå åå«æå»è¬çµæç© |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6226233A JPS6226233A (ja) | 1987-02-04 |
| JPH0369332B2 true JPH0369332B2 (ja) | 1991-10-31 |
Family
ID=10579735
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61122049A Granted JPS6226233A (ja) | 1985-05-28 | 1986-05-27 | çµç¹ãã©ã¹ããâã²ã³æŽ»æ§åå åå«æå»è¬çµæç© |
| JP61122050A Granted JPS6226234A (ja) | 1985-05-28 | 1986-05-27 | éçµå£æº¶æ¶²è£œå€ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61122050A Granted JPS6226234A (ja) | 1985-05-28 | 1986-05-27 | éçµå£æº¶æ¶²è£œå€ |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JPS6226233A (ja) |
| GB (1) | GB8513358D0 (ja) |
| ZA (2) | ZA863956B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
| JPS62292729A (ja) * | 1986-06-12 | 1987-12-19 | Toyobo Co Ltd | ããåå®®çµç¹ç±æ¥ãã©ã¹ããâã²ã³æŽ»æ§åå åè£œå€ |
| NO882226L (no) * | 1987-05-22 | 1988-11-23 | Zymogenetics Inc | Fibrinolytiske proteiner. |
| GB8814604D0 (en) * | 1988-06-20 | 1988-07-27 | Wellcome Found | Medicaments |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5728009A (en) * | 1980-06-11 | 1982-02-15 | Leuven Res & Dev Vzw | Novel plasminogen activator and drug having thrombosis dissolving activity |
| JPS5942321A (ja) * | 1982-05-05 | 1984-03-08 | ãžãšãã³ããã¯ã»ã€ã³ã³âãã¬ã€ããã | ããçµç¹ãã©ã¹ããâã²ã³æŽ»æ§åå å |
| JPS59118717A (ja) * | 1982-12-14 | 1984-07-09 | ãµãŠã¹ã¢ããªã«ã³ã»ã€ã³ãŽãšã³ã·ãšã³ãºã»ãã€ãŽãšãããã¡ã³ãã»ã³âãã¬âã·ãšã³ | ãã©ã¹ãããŒã²ã³æŽ»æ§åå€ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60181028A (ja) * | 1984-02-29 | 1985-09-14 | Asahi Chem Ind Co Ltd | çµç¹ãã©ã¹ããâã²ã³ã»ã¢ã¯ããâã¿âã®æº¶è§£è£å©æ³ |
| JPS60184026A (ja) * | 1984-03-01 | 1985-09-19 | Asahi Chem Ind Co Ltd | çµç¹ãã©ã¹ããâã²ã³ã»ã¢ã¯ããâã¿âã®æº¶è§£è£å©æ¹æ³ |
-
1985
- 1985-05-28 GB GB858513358A patent/GB8513358D0/en active Pending
-
1986
- 1986-05-27 ZA ZA863956A patent/ZA863956B/xx unknown
- 1986-05-27 JP JP61122049A patent/JPS6226233A/ja active Granted
- 1986-05-27 ZA ZA863955A patent/ZA863955B/xx unknown
- 1986-05-27 JP JP61122050A patent/JPS6226234A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5728009A (en) * | 1980-06-11 | 1982-02-15 | Leuven Res & Dev Vzw | Novel plasminogen activator and drug having thrombosis dissolving activity |
| JPS5942321A (ja) * | 1982-05-05 | 1984-03-08 | ãžãšãã³ããã¯ã»ã€ã³ã³âãã¬ã€ããã | ããçµç¹ãã©ã¹ããâã²ã³æŽ»æ§åå å |
| JPS59118717A (ja) * | 1982-12-14 | 1984-07-09 | ãµãŠã¹ã¢ããªã«ã³ã»ã€ã³ãŽãšã³ã·ãšã³ãºã»ãã€ãŽãšãããã¡ã³ãã»ã³âãã¬âã·ãšã³ | ãã©ã¹ãããŒã²ã³æŽ»æ§åå€ |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA863956B (en) | 1988-04-27 |
| GB8513358D0 (en) | 1985-07-03 |
| JPS6226234A (ja) | 1987-02-04 |
| JPS6338327B2 (ja) | 1988-07-29 |
| ZA863955B (en) | 1988-04-27 |
| JPS6226233A (ja) | 1987-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1300008C (en) | Acid lyophilised pharmaceutical formulation of tissue plasminogen activator | |
| CA1297008C (en) | Aqueous parenteral solution of tissue-plasminogen activator | |
| EP0875252B1 (en) | Activated protein C formulations | |
| US5407673A (en) | Fibrinolysis and fibrinogenolysis treatment | |
| EP0620738A1 (en) | Fibrinolysis and fibrinogenolysis treatment with plasmin | |
| JPH0672105B2 (ja) | è¡æ 溶解å€åã³ãã®è£œæ³ | |
| CA1297010C (en) | Combination of t-pa and a prostaglandin | |
| JPH0369332B2 (ja) | ||
| US20050143283A1 (en) | Activated protein c formulations | |
| US5342616A (en) | Method of administering tissue plasminogen activator | |
| JP2907447B2 (ja) | æè¡æ å€ | |
| CA1338551C (en) | Medicament for thrombotic disorder containing t-pa | |
| EP1561469A1 (en) | Activated Protein C Formulations |